| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dihydropyrimidinase activity | 1.03e-07 | 6 | 184 | 4 | GO:0004157 | |
| GeneOntologyMolecularFunction | actin filament binding | MICAL1 MYH4 MYH10 MYH11 NRAP SYNE1 SPTA1 SPTBN4 TLN1 MACF1 TLN2 CTNNA1 FMNL1 | 1.95e-07 | 227 | 184 | 13 | GO:0051015 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC3 MYH4 DNAH3 ABCF1 GBP2 CCT4 SRCAP OPA1 ATL1 RHEB ABCB4 HSPA13 TRAP1 GNAT3 MACF1 GNAI1 KIF2A GNAI3 GNAT2 DDX39A RAB32 RAB2A RAB5C KIF22 | 2.06e-07 | 775 | 184 | 24 | GO:0017111 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides | 2.53e-07 | 16 | 184 | 5 | GO:0016812 | |
| GeneOntologyMolecularFunction | actin binding | MICAL1 MYH4 MYH10 MYH11 NRAP SYNE1 SPTA1 RDX GBP2 SPTBN4 DST P4HB TLN1 MACF1 TLN2 CTNNA1 PALLD FMNL1 | 4.98e-07 | 479 | 184 | 18 | GO:0003779 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC3 MYH4 DNAH3 ABCF1 GBP2 CCT4 SRCAP OPA1 ATL1 RHEB ABCB4 HSPA13 TRAP1 GNAT3 MACF1 GNAI1 KIF2A GNAI3 GNAT2 DDX39A RAB32 RAB2A RAB5C KIF22 | 8.55e-07 | 839 | 184 | 24 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC3 MYH4 DNAH3 ABCF1 GBP2 CCT4 SRCAP OPA1 ATL1 RHEB ABCB4 HSPA13 TRAP1 GNAT3 MACF1 GNAI1 KIF2A GNAI3 GNAT2 DDX39A RAB32 RAB2A RAB5C KIF22 | 8.73e-07 | 840 | 184 | 24 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC3 MYH4 DNAH3 ABCF1 GBP2 CCT4 SRCAP OPA1 ATL1 RHEB ABCB4 HSPA13 TRAP1 GNAT3 MACF1 GNAI1 KIF2A GNAI3 GNAT2 DDX39A RAB32 RAB2A RAB5C KIF22 | 8.73e-07 | 840 | 184 | 24 | GO:0016818 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MICAL1 MYH4 DPYSL3 MYH10 MYH11 NRAP SYNE1 SPTA1 RDX DPYSL4 GBP2 OPA1 CRMP1 SPTBN4 RMDN3 HAUS8 DST P4HB TLN1 MACF1 TLN2 KIF2A CTNNA1 PALLD FMNL1 KIF22 | 9.37e-06 | 1099 | 184 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.93e-05 | 18 | 184 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | GTPase activating protein binding | 2.43e-05 | 19 | 184 | 4 | GO:0032794 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 7.59e-05 | 25 | 184 | 4 | GO:0031683 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.05e-04 | 51 | 184 | 5 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.51e-04 | 55 | 184 | 5 | GO:0061733 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.81e-04 | 31 | 184 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | vinculin binding | 2.06e-04 | 13 | 184 | 3 | GO:0017166 | |
| GeneOntologyMolecularFunction | integrin binding | 2.24e-04 | 175 | 184 | 8 | GO:0005178 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | PDE6C GBP2 OPA1 ATL1 RHEB THG1L GNAT3 GNAI1 GNAI3 GNAT2 RAB32 RAB2A RAB5C | 2.26e-04 | 439 | 184 | 13 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | PDE6C GBP2 OPA1 ATL1 RHEB THG1L GNAT3 GNAI1 GNAI3 GNAT2 RAB32 RAB2A RAB5C | 2.26e-04 | 439 | 184 | 13 | GO:0019001 |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.28e-04 | 60 | 184 | 5 | GO:0034212 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.32e-04 | 33 | 184 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 MYH4 DNAH3 ABCF1 CCT4 SRCAP ABCB4 HSPA13 TRAP1 MACF1 KIF2A DDX39A KIF22 | 2.36e-04 | 441 | 184 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | GTP binding | GBP2 OPA1 ATL1 RHEB THG1L GNAT3 GNAI1 GNAI3 GNAT2 RAB32 RAB2A RAB5C | 3.27e-04 | 397 | 184 | 12 | GO:0005525 |
| GeneOntologyMolecularFunction | GTPase activity | GBP2 OPA1 ATL1 RHEB GNAT3 GNAI1 GNAI3 GNAT2 RAB32 RAB2A RAB5C | 3.36e-04 | 341 | 184 | 11 | GO:0003924 |
| GeneOntologyMolecularFunction | GDP binding | 3.85e-04 | 103 | 184 | 6 | GO:0019003 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 4.06e-04 | 104 | 184 | 6 | GO:0016407 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | EPS15 GAPVD1 RDX ADAM11 DSCAML1 LGALS8 DST P4HB TLN1 MACF1 TLN2 CD81 CTNNA1 PALLD CDH17 | 4.53e-04 | 599 | 184 | 15 | GO:0050839 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 MYH4 DNAH3 MYH10 MYH11 ABCF1 CCT4 SRCAP ABCB4 HSPA13 TRAP1 MACF1 KIF2A DDX39A KIF22 | 5.85e-04 | 614 | 184 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 7.71e-04 | 78 | 184 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.92e-04 | 118 | 184 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor binding | 8.29e-04 | 5 | 184 | 2 | GO:0031821 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 1.68e-03 | 238 | 184 | 8 | GO:0016747 | |
| GeneOntologyMolecularFunction | filamin binding | 2.36e-03 | 29 | 184 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 2.36e-03 | 146 | 184 | 6 | GO:0016810 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 2.55e-03 | 102 | 184 | 5 | GO:0016410 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase catabolic process | 4.26e-07 | 8 | 185 | 4 | GO:0006208 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase metabolic process | 1.28e-06 | 22 | 185 | 5 | GO:0006206 | |
| GeneOntologyBiologicalProcess | nucleobase metabolic process | 2.92e-06 | 45 | 185 | 6 | GO:0009112 | |
| GeneOntologyBiologicalProcess | nucleobase catabolic process | 4.21e-06 | 13 | 185 | 4 | GO:0046113 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound catabolic process | 5.59e-05 | 46 | 185 | 5 | GO:0072529 | |
| GeneOntologyBiologicalProcess | intracellular transport | EPS15 FLOT2 MYH10 COPB1 COG7 SYNE1 RDX CPT1A OPA1 BCAP31 IPO9 DST FCGR2A P4HB BBS7 CD36 MCM3AP TTC21B CD81 KIF2A RAB11FIP4 EEA1 SPAG17 DDX39A RAB32 RAB2A SEC23A RAB5C KPNA3 | 6.78e-05 | 1496 | 185 | 29 | GO:0046907 |
| GeneOntologyCellularComponent | actin cytoskeleton | MICAL1 MYH4 FLOT2 DPYSL3 MYH10 MYH11 SPTA1 RDX GBP2 DGKH CRMP1 SPTBN4 DST MACF1 TLN2 MYH16 CTNNA1 PALLD | 3.88e-06 | 576 | 185 | 18 | GO:0015629 |
| GeneOntologyCellularComponent | melanosome | 7.50e-06 | 113 | 185 | 8 | GO:0042470 | |
| GeneOntologyCellularComponent | pigment granule | 7.50e-06 | 113 | 185 | 8 | GO:0048770 | |
| GeneOntologyCellularComponent | supramolecular fiber | DLGAP2 MICAL1 MYH4 DNAH3 DPYSL2 DPYSL3 MYH10 MYH11 NRAP RIBC2 KRT34 SYNE1 CCT4 OPA1 RYR2 SPTBN4 RMDN3 HAUS8 DST SYNJ1 PDE4DIP MACF1 KIF2A SPAG17 PALLD KIF22 | 1.59e-05 | 1179 | 185 | 26 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | DLGAP2 MICAL1 MYH4 DNAH3 DPYSL2 DPYSL3 MYH10 MYH11 NRAP RIBC2 KRT34 SYNE1 CCT4 OPA1 RYR2 SPTBN4 RMDN3 HAUS8 DST SYNJ1 PDE4DIP MACF1 KIF2A SPAG17 PALLD KIF22 | 1.79e-05 | 1187 | 185 | 26 | GO:0099081 |
| GeneOntologyCellularComponent | GTPase complex | 2.98e-05 | 41 | 185 | 5 | GO:1905360 | |
| GeneOntologyCellularComponent | cell leading edge | FLOT2 DPYSL3 TRPV1 MYH10 PSD3 RDX KSR1 MTMR6 DST P4HB TLN1 MACF1 TLN2 CTNNA1 PALLD | 4.09e-05 | 500 | 185 | 15 | GO:0031252 |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 1.36e-04 | 56 | 185 | 5 | GO:0031234 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | DLGAP2 MICAL1 DNAH3 DPYSL2 DPYSL3 RIBC2 KRT34 CCT4 OPA1 SPTBN4 RMDN3 HAUS8 DST SYNJ1 PDE4DIP MACF1 KIF2A SPAG17 PALLD KIF22 | 1.46e-04 | 899 | 185 | 20 | GO:0099513 |
| GeneOntologyCellularComponent | midbody | 1.67e-04 | 222 | 185 | 9 | GO:0030496 | |
| GeneOntologyCellularComponent | cell-substrate junction | FLOT2 NRAP PPFIA1 RDX NCSTN ABCB4 DST P4HB TLN1 TLN2 CD81 CTNNA1 PALLD | 1.67e-04 | 443 | 185 | 13 | GO:0030055 |
| GeneOntologyCellularComponent | endocytic vesicle | EPS15 FLOT2 GAPVD1 NCF2 APOB TLR9 ACE2 CD36 RAB11FIP4 RAB32 FMNL1 RAB5C | 1.68e-04 | 384 | 185 | 12 | GO:0030139 |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.89e-04 | 94 | 185 | 6 | GO:0044291 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 2.22e-04 | 137 | 185 | 7 | GO:0019897 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 2.49e-04 | 185 | 185 | 8 | GO:0009898 | |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 2.51e-04 | 35 | 185 | 4 | GO:0005834 | |
| GeneOntologyCellularComponent | microtubule | DNAH3 DPYSL2 RIBC2 CCT4 OPA1 RMDN3 HAUS8 DST SYNJ1 PDE4DIP MACF1 KIF2A SPAG17 KIF22 | 2.94e-04 | 533 | 185 | 14 | GO:0005874 |
| GeneOntologyCellularComponent | intercalated disc | 3.41e-04 | 68 | 185 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | FACT complex | 4.62e-04 | 4 | 185 | 2 | GO:0035101 | |
| GeneOntologyCellularComponent | focal adhesion | FLOT2 PPFIA1 RDX NCSTN ABCB4 DST P4HB TLN1 TLN2 CD81 CTNNA1 PALLD | 4.78e-04 | 431 | 185 | 12 | GO:0005925 |
| GeneOntologyCellularComponent | cell cortex | FLOT2 MYH10 SPTA1 RDX ITPR2 SPTBN4 DST PDE4DIP MACF1 GNAI1 FMNL1 | 4.88e-04 | 371 | 185 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | ruffle | 5.12e-04 | 206 | 185 | 8 | GO:0001726 | |
| GeneOntologyCellularComponent | axon | MICAL1 DPYSL2 DPYSL3 MYH10 SPTA1 PPFIA1 ADAM11 OPN1SW DSCAML1 OPA1 ATL1 CRMP1 ITPR2 SPTBN4 DST SYNJ1 EEA1 PALLD | 9.73e-04 | 891 | 185 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.05e-03 | 230 | 185 | 8 | GO:0098562 | |
| GeneOntologyCellularComponent | myosin filament | 1.36e-03 | 25 | 185 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment | 1.62e-03 | 141 | 185 | 6 | GO:0005793 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.64e-03 | 431 | 185 | 11 | GO:0031253 | |
| GeneOntologyCellularComponent | neuron spine | 1.65e-03 | 247 | 185 | 8 | GO:0044309 | |
| GeneOntologyCellularComponent | myosin complex | 1.85e-03 | 59 | 185 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin II complex | 1.90e-03 | 28 | 185 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | cleavage furrow | 2.09e-03 | 61 | 185 | 4 | GO:0032154 | |
| GeneOntologyCellularComponent | spectrin | 2.69e-03 | 9 | 185 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | ruffle membrane | 2.75e-03 | 108 | 185 | 5 | GO:0032587 | |
| GeneOntologyCellularComponent | somatodendritic compartment | DLGAP2 FLOT2 DPYSL2 TRPV1 MYH10 FXR2 SYNE1 PPFIA1 LAMA2 APOB ADAM11 OPA1 TRIM3 CRMP1 RHEB SPTBN4 SERPINE2 FCGR2A RAB2A PALLD SOS1 | 2.92e-03 | 1228 | 185 | 21 | GO:0036477 |
| GeneOntologyCellularComponent | vesicle membrane | EPS15 MICAL1 FLOT2 COPB1 GBP2 APOB NCSTN TLR9 ITPR2 ACE2 SYNJ1 FCGR2A CD36 LHFPL2 TAB1 RAB11FIP4 EEA1 RAB32 RAB2A SEC23A RAB5C MCOLN2 | 3.32e-03 | 1325 | 185 | 22 | GO:0012506 |
| GeneOntologyCellularComponent | flotillin complex | 3.35e-03 | 10 | 185 | 2 | GO:0016600 | |
| Domain | Hydantoinase/dihydroPyrase | 1.26e-07 | 6 | 181 | 4 | IPR011778 | |
| Domain | Gprotein_alpha_I | 5.79e-07 | 8 | 181 | 4 | IPR001408 | |
| Domain | - | 5.79e-07 | 8 | 181 | 4 | 2.30.40.10 | |
| Domain | Amidohydro_1 | 1.71e-06 | 10 | 181 | 4 | PF01979 | |
| Domain | Metal-dep_hydrolase_composite | 1.71e-06 | 10 | 181 | 4 | IPR011059 | |
| Domain | Spectrin | 2.36e-06 | 23 | 181 | 5 | PF00435 | |
| Domain | Amidohydro-rel | 2.67e-06 | 11 | 181 | 4 | IPR006680 | |
| Domain | Spectrin_repeat | 7.95e-06 | 29 | 181 | 5 | IPR002017 | |
| Domain | SPEC | 1.32e-05 | 32 | 181 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.32e-05 | 32 | 181 | 5 | IPR018159 | |
| Domain | GproteinA_insert | 1.42e-05 | 16 | 181 | 4 | IPR011025 | |
| Domain | - | 1.42e-05 | 16 | 181 | 4 | 1.10.400.10 | |
| Domain | G-alpha | 1.42e-05 | 16 | 181 | 4 | PF00503 | |
| Domain | G_alpha | 1.42e-05 | 16 | 181 | 4 | SM00275 | |
| Domain | Gprotein_alpha_su | 1.84e-05 | 17 | 181 | 4 | IPR001019 | |
| Domain | P-loop_NTPase | ABCC3 MYH4 DNAH3 MYH10 MYH11 ABCF1 GBP2 SRCAP OPA1 ATL1 RHEB ABCB4 GNAT3 GNAI1 KIF2A GNAI3 GNAT2 DDX39A RAB32 RAB2A RAB5C KIF22 | 2.55e-05 | 848 | 181 | 22 | IPR027417 |
| Domain | Vinculin/catenin | 3.04e-05 | 7 | 181 | 3 | IPR006077 | |
| Domain | ACTININ_2 | 6.54e-05 | 23 | 181 | 4 | PS00020 | |
| Domain | ACTININ_1 | 6.54e-05 | 23 | 181 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 6.54e-05 | 23 | 181 | 4 | IPR001589 | |
| Domain | Metal_Hydrolase | 7.79e-05 | 24 | 181 | 4 | IPR032466 | |
| Domain | - | 9.34e-05 | 2 | 181 | 2 | 1.20.1420.10 | |
| Domain | VBS | 9.34e-05 | 2 | 181 | 2 | PF08913 | |
| Domain | Vinculin-bd_dom | 9.34e-05 | 2 | 181 | 2 | IPR015009 | |
| Domain | Talin_cent | 9.34e-05 | 2 | 181 | 2 | IPR015224 | |
| Domain | Talin_middle | 9.34e-05 | 2 | 181 | 2 | PF09141 | |
| Domain | Talin-1 | 2.78e-04 | 3 | 181 | 2 | IPR015710 | |
| Domain | FERM_N | 2.80e-04 | 33 | 181 | 4 | IPR018979 | |
| Domain | FERM_N | 2.80e-04 | 33 | 181 | 4 | PF09379 | |
| Domain | Myosin_N | 3.74e-04 | 15 | 181 | 3 | PF02736 | |
| Domain | Myosin_N | 3.74e-04 | 15 | 181 | 3 | IPR004009 | |
| Domain | CH | 4.17e-04 | 65 | 181 | 5 | SM00033 | |
| Domain | ILWEQ_dom | 5.53e-04 | 4 | 181 | 2 | IPR002558 | |
| Domain | ILWEQ | 5.53e-04 | 4 | 181 | 2 | SM00307 | |
| Domain | FERM_f0 | 5.53e-04 | 4 | 181 | 2 | PF16511 | |
| Domain | ILWEQ | 5.53e-04 | 4 | 181 | 2 | PD011820 | |
| Domain | - | 5.53e-04 | 4 | 181 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 5.53e-04 | 4 | 181 | 2 | PF01608 | |
| Domain | I_LWEQ | 5.53e-04 | 4 | 181 | 2 | PS50945 | |
| Domain | FERM_f0 | 5.53e-04 | 4 | 181 | 2 | IPR032425 | |
| Domain | CH | 5.88e-04 | 70 | 181 | 5 | PF00307 | |
| Domain | - | 6.28e-04 | 71 | 181 | 5 | 1.10.418.10 | |
| Domain | Myosin_tail_1 | 6.56e-04 | 18 | 181 | 3 | PF01576 | |
| Domain | Myosin_tail | 6.56e-04 | 18 | 181 | 3 | IPR002928 | |
| Domain | CH | 7.13e-04 | 73 | 181 | 5 | PS50021 | |
| Domain | Myosin-like_IQ_dom | 7.74e-04 | 19 | 181 | 3 | IPR027401 | |
| Domain | - | 7.74e-04 | 19 | 181 | 3 | 4.10.270.10 | |
| Domain | CH-domain | 8.07e-04 | 75 | 181 | 5 | IPR001715 | |
| Domain | Myosin_S1_N | 9.16e-04 | 5 | 181 | 2 | IPR008989 | |
| Domain | - | ABCC3 DNAH3 ABCF1 GBP2 SRCAP OPA1 ATL1 RHEB ABCB4 GNAT3 GNAI1 GNAI3 GNAT2 DDX39A RAB32 RAB2A RAB5C | 9.65e-04 | 746 | 181 | 17 | 3.40.50.300 |
| Domain | FERM_M | 1.01e-03 | 46 | 181 | 4 | PF00373 | |
| Domain | - | 1.29e-03 | 49 | 181 | 4 | 1.20.80.10 | |
| Domain | FERM_central | 1.29e-03 | 49 | 181 | 4 | IPR019748 | |
| Domain | FERM_domain | 1.29e-03 | 49 | 181 | 4 | IPR000299 | |
| Domain | RIH_assoc-dom | 1.37e-03 | 6 | 181 | 2 | IPR013662 | |
| Domain | - | 1.37e-03 | 6 | 181 | 2 | 3.90.1290.10 | |
| Domain | GAR | 1.37e-03 | 6 | 181 | 2 | PS51460 | |
| Domain | Ins145_P3_rec | 1.37e-03 | 6 | 181 | 2 | PF08709 | |
| Domain | GAS2 | 1.37e-03 | 6 | 181 | 2 | PF02187 | |
| Domain | RIH_assoc | 1.37e-03 | 6 | 181 | 2 | PF08454 | |
| Domain | RIH_dom | 1.37e-03 | 6 | 181 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.37e-03 | 6 | 181 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.37e-03 | 6 | 181 | 2 | IPR015925 | |
| Domain | - | 1.37e-03 | 6 | 181 | 2 | 1.25.10.30 | |
| Domain | - | 1.37e-03 | 6 | 181 | 2 | 3.30.920.20 | |
| Domain | RYDR_ITPR | 1.37e-03 | 6 | 181 | 2 | PF01365 | |
| Domain | GAS_dom | 1.37e-03 | 6 | 181 | 2 | IPR003108 | |
| Domain | GAS2 | 1.37e-03 | 6 | 181 | 2 | SM00243 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 1.39e-03 | 50 | 181 | 4 | IPR014352 | |
| Domain | FERM_1 | 1.39e-03 | 50 | 181 | 4 | PS00660 | |
| Domain | FERM_2 | 1.39e-03 | 50 | 181 | 4 | PS00661 | |
| Domain | FERM_3 | 1.39e-03 | 50 | 181 | 4 | PS50057 | |
| Domain | Band_41_domain | 1.39e-03 | 50 | 181 | 4 | IPR019749 | |
| Domain | B41 | 1.39e-03 | 50 | 181 | 4 | SM00295 | |
| Domain | FERM_CS | 1.56e-03 | 24 | 181 | 3 | IPR019747 | |
| Domain | Plectin | 1.90e-03 | 7 | 181 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.90e-03 | 7 | 181 | 2 | IPR001101 | |
| Domain | PLEC | 1.90e-03 | 7 | 181 | 2 | SM00250 | |
| Domain | Disulphide_isomerase | 2.52e-03 | 8 | 181 | 2 | IPR005788 | |
| Domain | PH_dom-spectrin-type | 3.22e-03 | 9 | 181 | 2 | IPR001605 | |
| Domain | RuvA_2-like | 3.22e-03 | 9 | 181 | 2 | IPR010994 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 4.80e-06 | 64 | 149 | 7 | M7923 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.49e-05 | 15 | 149 | 4 | MM15031 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.98e-05 | 16 | 149 | 4 | M8245 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | DPYSL2 DPYSL3 SPTA1 RDX DPYSL4 NCSTN DSCAML1 CRMP1 SPTBN4 TLN1 SOS1 | 1.03e-04 | 261 | 149 | 11 | MM15676 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH10 MYH11 ABCF1 COPB1 SYNE1 SPTA1 SRM GPRIN3 CCT4 PSMD12 CPT1A SRCAP ECI1 GTF3C4 HNRNPL RMDN3 PDIA6 TRAP1 BCAP31 DST P4HB TLN1 TONSL MACF1 CTNNA1 EEA1 SPAG17 DDX39A RAB2A SEC23A RAB5C | 1.09e-17 | 807 | 188 | 31 | 30575818 |
| Pubmed | TPP2 DLGAP2 MICAL1 FLOT2 DPYSL2 DPYSL3 MYH10 MYH11 ABCF1 COPB1 SYNE1 SPTA1 PPFIA1 PSD3 RDX DPYSL4 CCT4 ECI1 OPA1 TRIM3 CRMP1 ITPR2 SPTBN4 PDIA6 SLC44A1 DST SYNJ1 P4HB TLN1 PDE4DIP MACF1 TLN2 GNAI1 KIF2A CTNNA1 RAB2A SEC23A RAB5C KPNA3 | 5.04e-17 | 1431 | 188 | 39 | 37142655 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPP2 EPS15 DPYSL2 NIBAN1 DPYSL3 GAPVD1 ABCF1 COPB1 ACAT2 COG7 PPFIA1 USP24 RDX GBP2 CCT4 PSMD12 SSRP1 GTF3C4 CRMP1 GMPS IVNS1ABP PDIA6 TRAP1 SERPINE2 IPO9 P4HB TLN1 THG1L MACF1 GNAI3 CTNNA1 TNFAIP8 SNRPA1 DDX39A FOXK1 SEC23A KPNA3 | 3.18e-15 | 1455 | 188 | 37 | 22863883 |
| Pubmed | MYH4 MYH10 CUX2 MYH11 KRT34 SYNE1 SPTA1 PPFIA1 RDX CCT4 APOB TEX14 SSRP1 SRBD1 SRCAP RYR2 ABCB4 SPTBN4 PDIA6 TRAP1 BCAP31 DST P4HB TCHHL1 CDK13 FAM169A MACF1 GNAI1 OTUD3 GNAI3 TNFAIP8 EEA1 SPAG17 DDX39A | 4.20e-13 | 1442 | 188 | 34 | 35575683 | |
| Pubmed | TPP2 FLOT2 DPYSL2 MYH10 FXR2 PPFIA1 USP24 SRM RDX CCT4 APOB PSMD12 NCSTN CPT1A TRRAP RHEB HSPA13 GMPS IVNS1ABP PDIA6 MTMR6 DST P4HB MACF1 GNAI3 EEA1 DDX39A RAB2A PALLD RAB5C KIF22 KPNA3 | 6.83e-13 | 1297 | 188 | 32 | 33545068 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPS15 DPYSL2 DPYSL3 MYH10 ABCF1 COPB1 ACAT2 FXR2 RDX CCT4 PSMD12 SSRP1 HNRNPL GMPS IVNS1ABP PDIA6 TRAP1 IPO9 DST P4HB TLN1 MACF1 TAB1 EEA1 SNRPA1 FOXK1 SEC23A RAB5C KPNA3 | 5.40e-12 | 1149 | 188 | 29 | 35446349 |
| Pubmed | TPP2 DLGAP2 EPS15 DPYSL2 MYH10 FXR2 SYNE1 PPFIA1 RDX DPYSL4 CCT4 OPA1 TRIM3 CRMP1 RHEB SPTBN4 DST SYNJ1 PDE4DIP MACF1 TLN2 GNAI1 KIF2A CTNNA1 RAB2A SEC23A | 1.75e-11 | 963 | 188 | 26 | 28671696 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | EPS15 FLOT2 GAPVD1 COPB1 COG7 SYNE1 GTF3C4 RMDN3 HAUS8 PDIA6 TRAP1 BCAP31 P4HB TLN1 GNAT3 TLN2 MAIP1 GNAI1 GNAI3 CTNNA1 EEA1 GNAT2 SNRPA1 ESPL1 DDX39A ZMYM4 RAB5C KPNA3 | 3.33e-11 | 1155 | 188 | 28 | 20360068 |
| Pubmed | GAPVD1 MYH10 COPB1 COG7 USP24 CCT4 PSMD12 SSRP1 HNRNPL GMPS PDIA6 TRAP1 BCAP31 IPO9 P4HB TLN1 KIF2A SNRPA1 FOXK1 SEC23A RAB5C | 5.00e-11 | 638 | 188 | 21 | 33239621 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPS15 FLOT2 DPYSL2 DPYSL3 GAPVD1 MYH10 ABCF1 COPB1 HLCS RDX DPYSL4 CCT4 SRCAP GTF3C4 RHEB GMPS PDIA6 TRAP1 ALDH1A2 DST SYNJ1 TLN1 FAM169A MACF1 PALLD | 5.32e-11 | 934 | 188 | 25 | 33916271 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLOT2 NIBAN1 GAPVD1 ABCF1 COPB1 SYNE1 CCT4 SSRP1 SRCAP TRRAP HNRNPL ITPR2 PDIA6 TRAP1 DST P4HB BBS7 TLN1 MACF1 KIF2A CTNNA1 EEA1 SNRPA1 SEC23A RAB5C KIF22 | 6.66e-11 | 1024 | 188 | 26 | 24711643 |
| Pubmed | DLGAP2 FLOT2 DPYSL2 MYH10 ABCF1 FXR2 USP24 PSD3 CCT4 PSMD12 ECI1 OPA1 RYR2 ATL1 RHEB GMPS TRAP1 SERPINE2 SYNJ1 P4HB PDE4DIP FAM169A MACF1 TLN2 KIF2A TAB1 SNRPA1 | 1.27e-10 | 1139 | 188 | 27 | 36417873 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | DPYSL2 DPYSL3 MYH10 MYH11 BMP2K SPTA1 CCT4 TRRAP OPA1 TRIM3 ATL1 HNRNPL CRMP1 TRAP1 DST SYNJ1 KIF2A GNAI3 GNAT2 SEC23A | 2.17e-10 | 621 | 188 | 20 | 22794259 |
| Pubmed | EPS15 FLOT2 GAPVD1 COPB1 PPFIA1 USP24 PSD3 HLCS RDX CCT4 PSMD12 OPA1 GMPS PDIA6 BCAP31 DST TLN1 MACF1 CTNNA1 SNRPA1 PALLD | 3.32e-10 | 708 | 188 | 21 | 39231216 | |
| Pubmed | TPP2 DPYSL2 DPYSL3 TRPV1 GAPVD1 ACAT2 USP24 CCT4 CRMP1 GMPS PDIA6 TRAP1 IPO9 P4HB CDK13 TLN1 FAM169A MAIP1 CTNNA1 DDX39A FOXK1 SEC23A KPNA3 | 5.06e-10 | 878 | 188 | 23 | 37223481 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DPYSL2 GAPVD1 FXR2 PPFIA1 CCT4 PSMD12 NCSTN CPT1A ECI1 OPA1 HNRNPL GMPS RMDN3 PDIA6 MTMR6 P4HB GNAI1 GNAI3 TAB1 CTNNA1 SNRPA1 ESPL1 FOXK1 RAB5C | 6.98e-10 | 974 | 188 | 24 | 28675297 |
| Pubmed | 8.27e-10 | 4 | 188 | 4 | 10664068 | ||
| Pubmed | The Ulip family phosphoproteins--common and specific properties. | 8.27e-10 | 4 | 188 | 4 | 9652388 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DPYSL2 MYH10 ABCF1 COPB1 ACAT2 SRM CCT4 SSRP1 SRBD1 SRCAP MIDEAS TRRAP GTF3C4 HNRNPL GMPS PDIA6 IPO9 DST P4HB TLN1 MCM3AP MACF1 KIF2A SNRPA1 DDX39A PALLD SEC23A KPNA3 | 1.19e-09 | 1353 | 188 | 28 | 29467282 |
| Pubmed | TET2 DPYSL2 ABCF1 COPB1 FXR2 RDX CCT4 PSMD12 SSRP1 HNRNPL PDIA6 TRAP1 P4HB TLN1 MACF1 GNAI3 CTNNA1 TAF10 SNRPA1 RAB5C | 2.22e-09 | 711 | 188 | 20 | 33022573 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | FLOT2 MYH10 NDUFAF5 BMP2K FXR2 SYNE1 CCT4 DGKH SSRP1 OPA1 ATL1 HNRNPL ITPR2 RMDN3 TRAP1 BCAP31 DST CDK13 TOX3 THG1L FAM169A AKAP11 KIF2A TAB1 ESPL1 GPAT4 MRPL1 SEC23A RAB5C | 2.54e-09 | 1496 | 188 | 29 | 32877691 |
| Pubmed | TPP2 EPS15 DPYSL2 CRMP1 PDIA6 MTMR6 IPO9 DST TLN1 MACF1 GNAI1 GNAI3 CTNNA1 ESPL1 | 2.91e-09 | 322 | 188 | 14 | 26514267 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLOT2 GAPVD1 MYH10 ABCF1 COPB1 SYNE1 KIAA0586 RDX CCT4 APOB PSMD12 SSRP1 OPA1 HNRNPL IVNS1ABP PDIA6 TRAP1 BCAP31 IPO9 P4HB TLN1 TLN2 KIF2A EEA1 SNRPA1 RAB2A SEC23A MCOLN2 | 3.69e-09 | 1425 | 188 | 28 | 30948266 |
| Pubmed | 4.12e-09 | 5 | 188 | 4 | 8973361 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | TPP2 DPYSL2 GAPVD1 MYH10 FBLL1 COPB1 CCT4 PSMD12 HNRNPL CRMP1 GMPS TRAP1 CDK13 TOX3 TAF10 SNRPA1 FOXK1 SEC23A RAB5C | 4.45e-09 | 665 | 188 | 19 | 30457570 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | EPS15 GAPVD1 ABCF1 BMP2K TRRAP GTF3C4 ITPR2 KSR1 BCAP31 DST CDK13 TLN1 PDE4DIP AKAP11 TAB1 TAF10 CPLANE1 ESPL1 PALLD MRPL1 FOXK1 SOS1 | 5.34e-09 | 910 | 188 | 22 | 36736316 |
| Pubmed | MYH10 MYH11 COPB1 FXR2 PPFIA1 RDX APOB SSRP1 MIDEAS GTF3C4 TRIM3 RHEB LGALS8 TRAP1 IPO9 P4HB TCHHL1 CDK13 TLN1 MCM3AP GNAI3 EEA1 TAF10 RAB2A SEC23A RAB5C KPNA3 | 6.91e-09 | 1371 | 188 | 27 | 36244648 | |
| Pubmed | TET2 DPYSL2 ABCF1 B4GAT1 COPB1 SYNE1 HLCS RDX DSCAML1 GTF3C4 CRMP1 HSPA13 SPTBN4 SERPINE2 DST SYNJ1 PDE4DIP MACF1 TLN2 CTNNA1 RAB11FIP4 PBX3 DKK3 ZMYM4 SOS1 KPNA3 | 7.83e-09 | 1285 | 188 | 26 | 35914814 | |
| Pubmed | 1.23e-08 | 6 | 188 | 4 | 10956643 | ||
| Pubmed | FLOT2 GAPVD1 MYH10 ABCF1 COPB1 FXR2 RDX CCT4 PSMD12 SSRP1 OPA1 HNRNPL GMPS BCAP31 IPO9 P4HB TLN1 GNAI1 KIF2A GNAI3 CTNNA1 DDX39A RAB2A KIF22 KPNA3 | 1.87e-08 | 1247 | 188 | 25 | 27684187 | |
| Pubmed | DPYSL3 GAPVD1 MYH10 DPYSL4 CCT4 SRCAP TRRAP GTF3C4 PDIA6 DST SYNJ1 CDK13 TLN1 GNAI3 TAF10 SNRPA1 | 1.94e-08 | 506 | 188 | 16 | 30890647 | |
| Pubmed | TPP2 DPYSL2 GAPVD1 MYH10 ABCF1 COPB1 FXR2 USP24 PSMD12 TRRAP GMPS DST P4HB TLN1 MCM3AP MACF1 CTNNA1 SEC23A | 2.00e-08 | 653 | 188 | 18 | 22586326 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH4 DNAH3 DPYSL2 FAT4 GAPVD1 FXR2 ZC2HC1C DGKH DSCAML1 HNRNPL ITPR2 GMPS IVNS1ABP DST TLN1 MCM3AP GNAT3 POTEA PCDH10 | 2.25e-08 | 736 | 188 | 19 | 29676528 |
| Pubmed | EPS15 FLOT2 NIBAN1 ABCF1 COPB1 FXR2 PSMD12 NCSTN CPT1A OPA1 HNRNPL LGALS8 ITPR2 KSR1 TRAP1 SLC44A1 BCAP31 IPO9 CD81 KIF2A GNAI3 DDX39A GPAT4 FMNL1 | 2.33e-08 | 1168 | 188 | 24 | 19946888 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPS15 DPYSL2 MYH10 ABCF1 COPB1 DPYSL4 CCT4 PSMD12 SSRP1 ECI1 OPA1 HNRNPL GMPS RMDN3 BCAP31 IPO9 P4HB TLN1 GNAI1 GNAI3 CTNNA1 SNRPA1 DDX39A PALLD FOXK1 SEC23A | 2.72e-08 | 1367 | 188 | 26 | 32687490 |
| Pubmed | MYH4 DPYSL2 DPYSL3 ABCF1 SYNE1 CCT4 OPA1 HNRNPL GMPS PDIA6 DST P4HB TLN1 MACF1 MAIP1 TAB1 CTNNA1 SNRPA1 PALLD SEC23A | 3.84e-08 | 844 | 188 | 20 | 25963833 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPP2 DNAH3 FLOT2 DPYSL2 DPYSL3 MYH10 MYH11 COPB1 RDX CCT4 PSMD12 SSRP1 SRCAP BCAP31 IPO9 TLN1 MACF1 TLN2 EEA1 DDX39A | 4.07e-08 | 847 | 188 | 20 | 35235311 |
| Pubmed | EPS15 ABCF1 FBLL1 BMP2K SYNE1 PPFIA1 CCT4 SSRP1 SRBD1 TRRAP CEP164 LGALS8 RMDN3 PDIA6 DST P4HB CDK13 TLN1 CXXC4 MACF1 KIF2A TAF10 ZMYM4 FOXK1 RAB5C KIF22 KPNA3 | 4.24e-08 | 1497 | 188 | 27 | 31527615 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | FLOT2 DPYSL2 DPYSL3 GAPVD1 MYH10 ABCF1 BMP2K FXR2 HLCS DPYSL4 CCT4 CEP164 HAUS8 MTMR6 ALDH1A2 SYNJ1 TLN1 GNAI3 TAB1 CPLANE1 | 4.57e-08 | 853 | 188 | 20 | 28718761 |
| Pubmed | CUX2 SYNE1 PSD3 DSCAML1 ZBTB24 DST SYNJ1 TLN1 MACF1 TLN2 AKAP11 | 4.60e-08 | 225 | 188 | 11 | 12168954 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DLGAP2 DPYSL2 SYNE1 PPFIA1 OPA1 CRMP1 SYNJ1 MACF1 TLN2 AKAP11 GNAI1 RAB2A | 4.93e-08 | 281 | 188 | 12 | 28706196 |
| Pubmed | Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | B4GAT1 NCSTN CPT1A OPA1 HSPA13 PDIA6 BCAP31 P4HB MAIP1 GNAI3 DDX39A RAB5C | 5.13e-08 | 282 | 188 | 12 | 35007762 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 FLOT2 DPYSL3 GAPVD1 PPFIA1 PSD3 SSRP1 IVNS1ABP FSIP2 HAUS8 KSR1 IPO9 DST SYNJ1 MACF1 AKAP11 KIF2A TAB1 PALLD FOXK1 | 5.31e-08 | 861 | 188 | 20 | 36931259 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPP2 MYH10 ABCF1 FXR2 KRT34 USP24 RDX CCT4 SSRP1 CPT1A OPA1 HNRNPL GMPS PDIA6 DNAJC17 P4HB CDK13 TLN1 MACF1 KIF2A CTNNA1 SNRPA1 PALLD FOXK1 SEC23A RAB5C | 5.39e-08 | 1415 | 188 | 26 | 28515276 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MYH10 ABCF1 COPB1 BMP2K FXR2 USP24 HLCS RDX CCT4 PSMD12 SSRP1 OPA1 HNRNPL RHEB GMPS TRAP1 IPO9 KIF2A TAF10 SNRPA1 DDX39A RAB2A MRPL1 RAB5C KIF22 | 5.45e-08 | 1318 | 188 | 25 | 30463901 |
| Pubmed | CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. | 5.69e-08 | 8 | 188 | 4 | 12134159 | |
| Pubmed | DPYSL2 DPYSL3 GAPVD1 FBLL1 USP24 SSRP1 SRCAP MIDEAS TRRAP GTF3C4 MTMR6 SYNJ1 TLN1 TAB1 PALLD ZMYM4 | 5.96e-08 | 549 | 188 | 16 | 38280479 | |
| Pubmed | MICAL1 MYH10 MYH11 PSD3 APOB OPA1 TRIM3 RNF214 IPO9 CD81 RAB2A | 6.57e-08 | 233 | 188 | 11 | 29518331 | |
| Pubmed | EPS15 FLOT2 MYH10 ABCF1 COPB1 BMP2K SRM CCT4 SSRP1 HNRNPL GMPS PDIA6 TRAP1 TLN1 MACF1 GNAI3 SNRPA1 RAB5C | 6.62e-08 | 707 | 188 | 18 | 19738201 | |
| Pubmed | DNAH3 FLOT2 DPYSL2 DPYSL3 MYH10 SYNE1 CCT4 PSMD12 HNRNPL LGALS8 GMPS PDIA6 TRAP1 P4HB TLN1 DDX39A RAB32 RAB2A RAB5C | 8.78e-08 | 803 | 188 | 19 | 36517590 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | TPP2 MYH10 ABCF1 COPB1 USP24 RDX TRIM3 ATL1 GMPS DST CDK13 MACF1 TLN2 KIF2A CTNNA1 | 1.03e-07 | 498 | 188 | 15 | 36634849 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.35e-07 | 197 | 188 | 10 | 20811636 | |
| Pubmed | MYH10 ABCF1 FXR2 PPFIA1 CCT4 SSRP1 HNRNPL GMPS TRAP1 KIF2A TAB1 FOXK1 KIF22 KPNA3 | 1.47e-07 | 441 | 188 | 14 | 31239290 | |
| Pubmed | 1.55e-07 | 3 | 188 | 3 | 11771764 | ||
| Pubmed | The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. | 1.69e-07 | 10 | 188 | 4 | 8521505 | |
| Pubmed | MYH10 ABCF1 COPB1 FXR2 RDX CCT4 SSRP1 OPA1 GTF3C4 HNRNPL ZNF701 KIF2A FOXK1 SEC23A | 1.93e-07 | 451 | 188 | 14 | 36168627 | |
| Pubmed | DPH1 ABCC3 MYH10 NDUFAF5 ACAT2 SRM TRRAP MEIS2 CRMP1 GMPS RNF214 SLC44A1 IPO9 P4HB CDK13 MCM3AP FAM169A NDUFAF6 RAB2A ZMYM4 FOXK1 RAB5C SOS1 KPNA3 | 2.45e-07 | 1327 | 188 | 24 | 32694731 | |
| Pubmed | Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. | 2.52e-07 | 79 | 188 | 7 | 17081065 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FLOT2 MYH10 MYH11 ABCF1 COPB1 BMP2K FXR2 SYNE1 RDX CCT4 APOB SSRP1 HNRNPL DST CDK13 KIF2A GNAI3 CTNNA1 DDX39A KIF22 | 2.52e-07 | 949 | 188 | 20 | 36574265 |
| Pubmed | TPP2 DPYSL3 MYH10 PPFIA1 PSD3 PPM1M GPRIN3 CCT4 PSMD12 OPA1 HNRNPL ITPR2 GMPS PDIA6 MTMR6 IPO9 P4HB TAB1 CTNNA1 KIF22 KPNA3 | 2.88e-07 | 1049 | 188 | 21 | 27880917 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | B4GAT1 COG7 APOB PSMD12 ECI1 RHEB HSPA13 BCAP31 SERPINE2 ALDH1A2 MCM3AP PDE4DIP MACF1 CD81 MAIP1 CTNNA1 EEA1 RAB32 RAB2A GPAT4 CDH17 | 3.46e-07 | 1061 | 188 | 21 | 33845483 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | DPYSL2 MYH10 COPB1 USP24 RDX CCT4 TRRAP HNRNPL GMPS IPO9 TLN1 SEC23A | 4.35e-07 | 344 | 188 | 12 | 30333137 |
| Pubmed | DPYSL2 FXR2 RDX CCT4 SSRP1 SRBD1 PDIA6 DST CDK13 KIF2A CTNNA1 SNRPA1 DDX39A RAB2A MRPL1 RAB5C KIF22 | 4.73e-07 | 723 | 188 | 17 | 34133714 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLOT2 DPYSL2 MYH10 ABCF1 FBLL1 SYNE1 DPYSL4 SSRP1 SRCAP TRRAP OPA1 HNRNPL CRMP1 PDIA6 DST P4HB MACF1 KIF2A SNRPA1 DDX39A KPNA3 | 4.76e-07 | 1082 | 188 | 21 | 38697112 |
| Pubmed | FLOT2 DPYSL2 RDX CCT4 NCSTN RHEB PDIA6 SLC44A1 CD101 TLN1 CD81 GNAI3 RAB2A FMNL1 RAB5C | 5.11e-07 | 565 | 188 | 15 | 20458337 | |
| Pubmed | Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein. | 5.69e-07 | 13 | 188 | 4 | 8208289 | |
| Pubmed | Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins. | 5.69e-07 | 13 | 188 | 4 | 16892066 | |
| Pubmed | Amino- and carboxyl-terminal domains of Filamin-A interact with CRMP1 to mediate Sema3A signalling. | 6.19e-07 | 4 | 188 | 3 | 25358863 | |
| Pubmed | DPYSL2 B4GAT1 BMP2K NCSTN SSRP1 HSPA13 HAUS8 PDIA6 BCAP31 DNAJC17 SYNJ1 P4HB MCM3AP TAB1 DDX39A RAB32 PALLD GPAT4 ZMYM4 KPNA3 | 6.36e-07 | 1007 | 188 | 20 | 34597346 | |
| Pubmed | TPP2 TET2 ABCF1 SRM CCT4 PSMD12 SSRP1 MIDEAS TRRAP HNRNPL GMPS BCAP31 CDK13 TLN1 KIF2A TAF10 SNRPA1 DDX39A RAB2A ZMYM4 FOXK1 | 6.48e-07 | 1103 | 188 | 21 | 34189442 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 6.84e-07 | 235 | 188 | 10 | 30258100 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | FLOT2 MYH10 MYH11 COPB1 FXR2 SRM CCT4 SSRP1 CPT1A LGALS8 PDIA6 P4HB GNAI1 KIF2A GNAI3 | 7.09e-07 | 580 | 188 | 15 | 35676659 |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 7.19e-07 | 182 | 188 | 9 | 31067453 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | COPB1 PPFIA1 USP24 CCT4 PSMD12 GMPS TRAP1 IPO9 TLN1 MACF1 TLN2 CTNNA1 SNRPA1 DDX39A SEC23A | 7.41e-07 | 582 | 188 | 15 | 20467437 |
| Pubmed | FLOT2 FBLL1 RIBC2 FXR2 PPFIA1 GPT HLCS SSRP1 SRCAP TRRAP OPA1 RMDN3 KSR1 MCM3AP MACF1 MAIP1 TAF10 C1orf50 FOXK1 SOS1 KPNA3 | 7.82e-07 | 1116 | 188 | 21 | 31753913 | |
| Pubmed | 1.08e-06 | 15 | 188 | 4 | 11118617 | ||
| Pubmed | FLOT2 PPFIA1 SRM CCT4 ITPR2 HSPA13 GMPS PDIA6 TRAP1 BCAP31 P4HB AKAP11 CTNNA1 RAB32 RAB2A PCDH10 GPAT4 SEC23A RAB5C | 1.15e-06 | 952 | 188 | 19 | 38569033 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | ABCF1 FXR2 PSMD12 SRBD1 GTF3C4 HNRNPL IVNS1ABP PDIA6 TAB1 SNRPA1 DDX39A | 1.36e-06 | 316 | 188 | 11 | 31665637 |
| Pubmed | 1.54e-06 | 5 | 188 | 3 | 16611631 | ||
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | FLOT2 MYH10 PSMD12 NCSTN CPT1A GMPS GNAI3 SNRPA1 RAB32 RAB2A SEC23A RAB5C | 1.71e-06 | 392 | 188 | 12 | 33144569 |
| Pubmed | NIBAN1 DPYSL4 CPT1A SLC44A1 AKAP11 TAB1 CTNNA1 EEA1 FOXK1 SEC23A KIF22 | 1.78e-06 | 325 | 188 | 11 | 36168628 | |
| Pubmed | TPP2 DPYSL2 DPYSL3 MYH10 COPB1 COG7 CCT4 PDIA6 P4HB TLN1 SEC23A RAB5C | 1.94e-06 | 397 | 188 | 12 | 21319273 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH4 GAPVD1 MYH10 ACAT2 FXR2 KRT34 PSMD12 TRRAP OPA1 ZBTB24 HNRNPL RMDN3 PDIA6 IPO9 P4HB TONSL AKAP11 TNFAIP8 SNRPA1 FOXK1 RAB5C KPNA3 | 1.96e-06 | 1284 | 188 | 22 | 17353931 |
| Pubmed | GAPVD1 BMP2K PPFIA1 APOB NCSTN SRCAP ZBTB24 CRMP1 MTMR6 SLC44A1 SYNJ1 P4HB MACF1 KIF2A GNAI3 CPLANE1 ESPL1 DDX39A RAB2A KPNA3 | 1.96e-06 | 1084 | 188 | 20 | 11544199 | |
| Pubmed | COPB1 CCT4 PSMD12 GTF3C4 GMPS CDK13 TLN1 CTNNA1 EEA1 SNRPA1 RAB2A KIF22 | 2.05e-06 | 399 | 188 | 12 | 37536630 | |
| Pubmed | DPYSL2 DPYSL3 MYH10 MYH11 PDE6C DPYSL4 CCT4 OPN1SW HNRNPL CRMP1 SYNJ1 P4HB FAM169A GNAT2 | 2.11e-06 | 552 | 188 | 14 | 36293380 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | GAPVD1 ABCF1 CCT4 SRCAP GTF3C4 HNRNPL P4HB TLN1 KIF2A DDX39A PALLD | 2.19e-06 | 332 | 188 | 11 | 32786267 |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 2.38e-06 | 18 | 188 | 4 | 12119179 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC3 DPYSL2 FAT4 DPYSL3 ABCF1 B4GAT1 NCSTN CPT1A ECI1 ITPR2 HSPA13 PDIA6 BCAP31 SERPINE2 P4HB KIF2A GNAI3 CTNNA1 PALLD GPAT4 RAB5C | 2.49e-06 | 1201 | 188 | 21 | 35696571 |
| Pubmed | FLOT2 MYH10 COPB1 CCT4 NCSTN SSRP1 PDIA6 BCAP31 TLN1 GNAI3 TAB1 RAB2A SEC23A | 2.65e-06 | 484 | 188 | 13 | 31995728 | |
| Pubmed | Mice carrying a complete deletion of the talin2 coding sequence are viable and fertile. | 3.07e-06 | 6 | 188 | 3 | 22925892 | |
| Pubmed | 3.07e-06 | 6 | 188 | 3 | 25078664 | ||
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | TPP2 CCT4 HNRNPL GMPS IVNS1ABP PDIA6 BCAP31 P4HB TLN1 TLN2 RAB2A RAB5C | 3.30e-06 | 418 | 188 | 12 | 32552912 |
| Pubmed | TPP2 MYH10 COPB1 CCT4 PSMD12 HNRNPL GMPS P4HB TLN1 CTNNA1 PALLD SEC23A KPNA3 | 3.31e-06 | 494 | 188 | 13 | 26831064 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | FLOT2 COPB1 CPT1A OPA1 IVNS1ABP BCAP31 P4HB TLN1 GNAI1 GNAI3 RAB2A SEC23A | 3.64e-06 | 422 | 188 | 12 | 27342126 |
| Pubmed | ABCF1 NDUFAF5 CCT4 PSMD12 SSRP1 TRRAP OPA1 GTF3C4 HNRNPL GMPS PDIA6 TRAP1 IPO9 P4HB MAIP1 KIF2A CTNNA1 SNRPA1 MRPL1 SEC23A RAB5C KPNA3 | 3.66e-06 | 1335 | 188 | 22 | 29229926 | |
| Pubmed | 3.83e-06 | 118 | 188 | 7 | 30979931 | ||
| Pubmed | 3.86e-06 | 285 | 188 | 10 | 21423176 | ||
| Pubmed | FAT4 DPYSL3 SYNE1 GBP2 APOB PSMD12 SSRP1 TRRAP HNRNPL CRMP1 GMPS IVNS1ABP P4HB DDX39A ZMYM4 RAB5C | 3.88e-06 | 754 | 188 | 16 | 35906200 | |
| Pubmed | 5.35e-06 | 7 | 188 | 3 | 34860335 | ||
| Interaction | AGR2 interactions | MYH10 MYH11 ABCF1 NRAP COPB1 SYNE1 SPTA1 SRM GPRIN3 CCT4 PSMD12 CPT1A SRCAP ECI1 GTF3C4 HNRNPL CRMP1 RMDN3 PDIA6 TRAP1 BCAP31 DST P4HB TLN1 TONSL MACF1 CTNNA1 EEA1 SPAG17 DDX39A RAB2A SEC23A RAB5C | 1.99e-11 | 934 | 184 | 33 | int:AGR2 |
| Interaction | KCTD13 interactions | TPP2 DLGAP2 MICAL1 FLOT2 DPYSL2 DPYSL3 MYH10 MYH11 ABCF1 COPB1 SYNE1 SPTA1 PPFIA1 PSD3 RDX DPYSL4 CCT4 ECI1 OPA1 TRIM3 CRMP1 ITPR2 SPTBN4 PDIA6 SLC44A1 DST SYNJ1 P4HB TLN1 MACF1 TLN2 GNAI1 KIF2A CTNNA1 RAB2A SEC23A RAB5C KPNA3 | 9.23e-10 | 1394 | 184 | 38 | int:KCTD13 |
| Interaction | ACTB interactions | TET2 EPS15 TRPV1 MYH10 MYH11 NRAP COG7 PPFIA1 RDX CCT4 SRCAP ECI1 MEIS2 HNRNPL IVNS1ABP FSIP2 ACE2 MTMR6 TRAP1 BCAP31 IPO9 DST P4HB MACF1 CD81 CTNNA1 DDX39A RAB2A PALLD | 1.79e-07 | 1083 | 184 | 29 | int:ACTB |
| Interaction | NAA40 interactions | TPP2 EPS15 FLOT2 DPYSL2 DPYSL3 GAPVD1 MYH10 ABCF1 COPB1 HLCS RDX DPYSL4 CCT4 SSRP1 SRCAP GTF3C4 RHEB GMPS PDIA6 TRAP1 ALDH1A2 DST SYNJ1 TLN1 FAM169A MACF1 PALLD | 2.76e-07 | 978 | 184 | 27 | int:NAA40 |
| Interaction | RGS14 interactions | MICAL1 MYH10 MYH11 PSD3 APOB OPA1 TRIM3 RNF214 IPO9 CD81 GNAI1 GNAI3 RAB2A | 3.34e-07 | 240 | 184 | 13 | int:RGS14 |
| Interaction | MTNR1B interactions | 4.63e-07 | 135 | 184 | 10 | int:MTNR1B | |
| Interaction | H2BC6 interactions | 1.52e-06 | 62 | 184 | 7 | int:H2BC6 | |
| Interaction | PTPRU interactions | 2.09e-06 | 124 | 184 | 9 | int:PTPRU | |
| Interaction | GNG4 interactions | 2.75e-06 | 25 | 184 | 5 | int:GNG4 | |
| Interaction | KCNA3 interactions | EPS15 FLOT2 GAPVD1 COPB1 PPFIA1 USP24 PSD3 HLCS RDX CCT4 PSMD12 OPA1 GMPS PDIA6 BCAP31 DST TLN1 MACF1 TLN2 CTNNA1 SNRPA1 DDX39A PALLD | 4.81e-06 | 871 | 184 | 23 | int:KCNA3 |
| Interaction | SERBP1 interactions | TPP2 DPYSL2 DPYSL3 TRPV1 GAPVD1 ACAT2 FXR2 USP24 RDX CCT4 TRRAP TRIM3 CRMP1 GMPS ACE2 PDIA6 TRAP1 IPO9 P4HB CDK13 TLN1 FAM169A CD81 MAIP1 KIF2A CTNNA1 DDX39A MRPL1 FOXK1 SEC23A KPNA3 | 5.94e-06 | 1432 | 184 | 31 | int:SERBP1 |
| Interaction | MCM2 interactions | MYH4 DPYSL2 DPYSL3 GAPVD1 ABCF1 SYNE1 CCT4 SSRP1 TRRAP OPA1 GTF3C4 HNRNPL GMPS IVNS1ABP PDIA6 DST P4HB TLN1 TONSL MACF1 MAIP1 TAB1 CTNNA1 SNRPA1 PALLD SEC23A | 5.95e-06 | 1081 | 184 | 26 | int:MCM2 |
| Interaction | HTT interactions | DPYSL2 DPYSL3 MYH10 MYH11 BMP2K SPTA1 USP24 CCT4 TRRAP OPA1 TRIM3 ATL1 HNRNPL CRMP1 RHEB TRAP1 IPO9 DST SYNJ1 CD36 KIF2A GNAI3 GNAT2 SEC23A | 6.12e-06 | 949 | 184 | 24 | int:HTT |
| Interaction | ECT2 interactions | FLOT2 MYH10 MYH11 ABCF1 FBLL1 FXR2 CCT4 SSRP1 TRRAP CEP164 HNRNPL ITPR2 SPTBN4 TRAP1 IPO9 DST P4HB GNAT3 MACF1 GNAI1 GNAI3 MRPL1 RAB5C | 6.48e-06 | 887 | 184 | 23 | int:ECT2 |
| Interaction | BAP1 interactions | EPS15 DPYSL2 DPYSL3 MYH10 ABCF1 COPB1 ACAT2 FXR2 RDX CCT4 PSMD12 SSRP1 HNRNPL GMPS IVNS1ABP PDIA6 TRAP1 IPO9 DST P4HB TLN1 MACF1 TAB1 EEA1 SNRPA1 FOXK1 SEC23A RAB5C KPNA3 | 8.60e-06 | 1314 | 184 | 29 | int:BAP1 |
| Interaction | GNAT3 interactions | 1.12e-05 | 16 | 184 | 4 | int:GNAT3 | |
| Interaction | TERF2 interactions | TPP2 MYH10 BMP2K FXR2 SYNE1 SSRP1 RYR2 DST CDK13 TLN1 MCM3AP MACF1 DDX39A | 1.55e-05 | 340 | 184 | 13 | int:TERF2 |
| Interaction | SLC38A9 interactions | 1.56e-05 | 35 | 184 | 5 | int:SLC38A9 | |
| Interaction | STIP1 interactions | GAPVD1 MYH10 COPB1 COG7 USP24 PPM1M RDX CCT4 PSMD12 SSRP1 HNRNPL GMPS PDIA6 TRAP1 BCAP31 IPO9 P4HB TLN1 KIF2A CTNNA1 SNRPA1 FOXK1 SEC23A RAB5C | 1.61e-05 | 1006 | 184 | 24 | int:STIP1 |
| Interaction | MYH9 interactions | TET2 EPS15 GAPVD1 MYH10 MYH11 BMP2K APOB MIDEAS TRRAP ITPR2 IVNS1ABP ACE2 TRAP1 BCAP31 DST TLN1 MACF1 GNAI1 OTUD3 PALLD | 1.96e-05 | 754 | 184 | 20 | int:MYH9 |
| Interaction | FGD5 interactions | 2.13e-05 | 207 | 184 | 10 | int:FGD5 | |
| Interaction | GPM6A interactions | 2.47e-05 | 168 | 184 | 9 | int:GPM6A | |
| Interaction | TRPM4 interactions | 3.05e-05 | 40 | 184 | 5 | int:TRPM4 | |
| Interaction | CANX interactions | ADGRG5 ABCC3 DNAH3 B4GAT1 COPB1 CCT4 APOB NCSTN TRRAP LGALS8 HSPA13 FSIP2 ACE2 PDIA6 SLC44A1 BCAP31 ALDH1A2 IPO9 P4HB FAM169A KIF2A GNAI3 RAB2A GPAT4 SEC23A RAB5C KPNA3 | 3.11e-05 | 1261 | 184 | 27 | int:CANX |
| Interaction | CCDC8 interactions | FLOT2 NIBAN1 GAPVD1 ABCF1 COPB1 APOB HNRNPL ITPR2 PDIA6 TRAP1 DST P4HB BBS7 MACF1 CTNNA1 EEA1 RAB2A RAB5C | 3.37e-05 | 656 | 184 | 18 | int:CCDC8 |
| Interaction | GSK3B interactions | MICAL1 DPYSL2 GAPVD1 PPFIA1 KIAA0586 GBP2 CCT4 TLR9 SSRP1 GMPS SPTBN4 TRAP1 DST P4HB TONSL MACF1 AKAP11 TAB1 CTNNA1 PALLD DKK3 | 4.64e-05 | 868 | 184 | 21 | int:GSK3B |
| Interaction | RAC2 interactions | FLOT2 PPFIA1 PSD3 RDX NCF2 TRRAP RMDN3 BCAP31 DST MACF1 TLN2 CD81 CTNNA1 RAB32 RAB2A GPAT4 FMNL1 RAB5C | 4.78e-05 | 674 | 184 | 18 | int:RAC2 |
| Interaction | H2BC9 interactions | MYH10 ABCF1 ADAMTS2 LAMA2 SSRP1 TRRAP FSIP2 IPO9 DST PDE4DIP AKAP11 CD81 SPAG17 PALLD | 6.36e-05 | 446 | 184 | 14 | int:H2BC9 |
| Interaction | YWHAH interactions | TET2 FLOT2 DPYSL3 GAPVD1 MYH11 FXR2 PPFIA1 PSD3 ZNF395 SSRP1 IVNS1ABP RMDN3 HAUS8 KSR1 IPO9 DST SYNJ1 MACF1 AKAP11 KIF2A GNAI3 TAB1 PALLD FOXK1 | 6.88e-05 | 1102 | 184 | 24 | int:YWHAH |
| Interaction | KIF23 interactions | MICAL1 FLOT2 MYH10 MYH11 ABCF1 COPB1 FXR2 LAMA2 CCT4 PSMD12 TEX14 SSRP1 OPA1 HNRNPL ITPR2 PDIA6 TRAP1 P4HB GNAT3 MACF1 GNAI1 GNAI3 SEC23A | 6.88e-05 | 1031 | 184 | 23 | int:KIF23 |
| Interaction | ACTC1 interactions | DPYSL3 GAPVD1 MYH10 SYNE1 DPYSL4 CCT4 SRCAP TRRAP GTF3C4 PDIA6 DST SYNJ1 CDK13 TLN1 GNAI3 TAF10 SNRPA1 ZMYM4 | 6.96e-05 | 694 | 184 | 18 | int:ACTC1 |
| Interaction | ALCAM interactions | 7.40e-05 | 77 | 184 | 6 | int:ALCAM | |
| Interaction | ATXN1 interactions | TPP2 DPYSL2 FAT4 GAPVD1 MYH10 FBLL1 COPB1 CCT4 PSMD12 HNRNPL CRMP1 GMPS MTMR6 TRAP1 CDK13 TOX3 TAB1 TAF10 SNRPA1 FOXK1 SEC23A RAB5C KIF22 | 7.73e-05 | 1039 | 184 | 23 | int:ATXN1 |
| Interaction | OBSL1 interactions | FLOT2 ABCF1 FXR2 SYNE1 PSMD12 SSRP1 SRCAP MIDEAS TRRAP HNRNPL PDIA6 TRAP1 DST TLN1 MACF1 KIF2A CTNNA1 SNRPA1 RAB2A SEC23A KIF22 | 8.02e-05 | 902 | 184 | 21 | int:OBSL1 |
| Interaction | HNRNPD interactions | DNAH3 B4GAT1 COG7 USP24 SSRP1 TRRAP HNRNPL IVNS1ABP ACE2 RMDN3 P4HB TLN1 TLN2 CD81 ESPL1 MRPL1 ZMYM4 | 8.04e-05 | 638 | 184 | 17 | int:HNRNPD |
| Interaction | HAX1 interactions | FLOT2 DPYSL2 DPYSL3 DPYSL4 DGKH OPA1 CRMP1 ABCB4 ITPR2 TOX3 AKAP11 ESPL1 RAB2A | 9.11e-05 | 404 | 184 | 13 | int:HAX1 |
| Interaction | FN1 interactions | EPS15 FLOT2 MYH10 ABCF1 COPB1 BMP2K SRM CCT4 HNRNPL LGALS8 GMPS ACE2 PDIA6 TRAP1 TLN1 MACF1 GNAI3 TAB1 SEC23A RAB5C | 1.01e-04 | 848 | 184 | 20 | int:FN1 |
| Interaction | RPN2 interactions | NIBAN1 SYNE1 DPYSL4 APOB CPT1A TRRAP ATL1 ITPR2 ACE2 SLC44A1 BCAP31 IPO9 TONSL TAB1 CTNNA1 EEA1 RAB2A GPAT4 SEC23A | 1.03e-04 | 782 | 184 | 19 | int:RPN2 |
| Interaction | IFITM1 interactions | FLOT2 NIBAN1 MYH10 FXR2 APOB TRRAP MTMR6 CD81 GNAI3 EEA1 PCDH10 SEC23A | 1.08e-04 | 355 | 184 | 12 | int:IFITM1 |
| Interaction | SUMO2 interactions | GAPVD1 ABCF1 CCT4 SSRP1 SRCAP GTF3C4 HNRNPL ACE2 DST P4HB TLN1 KIF2A DDX39A PALLD ZMYM4 SEC23A | 1.09e-04 | 591 | 184 | 16 | int:SUMO2 |
| Interaction | CYFIP1 interactions | DPYSL2 FXR2 DPYSL4 OPA1 TRIM3 CRMP1 RHEB ACE2 MACF1 KIF2A CTNNA1 | 1.12e-04 | 303 | 184 | 11 | int:CYFIP1 |
| Interaction | CDC5L interactions | TET2 COPB1 SYNE1 PPFIA1 USP24 CCT4 PSMD12 GMPS TRAP1 DNAJC17 IPO9 DST TLN1 PDE4DIP MACF1 TLN2 CTNNA1 SNRPA1 DDX39A SEC23A | 1.12e-04 | 855 | 184 | 20 | int:CDC5L |
| Interaction | PLD4 interactions | 1.13e-04 | 83 | 184 | 6 | int:PLD4 | |
| Interaction | VCL interactions | TRPV1 NRAP CRMP1 HAUS8 DST SYNJ1 TLN1 TTC21B MACF1 GNAI3 CTNNA1 | 1.19e-04 | 305 | 184 | 11 | int:VCL |
| Interaction | EED interactions | FLOT2 GAPVD1 MYH10 MYH11 ABCF1 COPB1 BMP2K FXR2 CCT4 PSMD12 SSRP1 TRRAP GTF3C4 HNRNPL RHEB GMPS PDIA6 IPO9 SYNJ1 TLN1 TTC21B MACF1 CTNNA1 SNRPA1 DDX39A RAB2A SEC23A RAB5C | 1.24e-04 | 1445 | 184 | 28 | int:EED |
| Interaction | CHMP4B interactions | FLOT2 TRPV1 MYH10 MYH11 FBLL1 FXR2 RDX HNRNPL SPTBN4 TRAP1 GNAT3 TLN2 AKAP11 GNAI1 GNAI3 SNRPA1 RAB2A RAB5C | 1.25e-04 | 727 | 184 | 18 | int:CHMP4B |
| Interaction | MYCN interactions | MYH10 ABCF1 ADAMTS2 FXR2 SYNE1 PPFIA1 CCT4 APOB SSRP1 SRBD1 MIDEAS TRRAP GTF3C4 HNRNPL DNAJC17 P4HB CDK13 MAIP1 TAF10 PBX3 SNRPA1 DDX39A MRPL1 FOXK1 SEC23A RAB5C KPNA3 | 1.31e-04 | 1373 | 184 | 27 | int:MYCN |
| Interaction | DPYSL3 interactions | 1.37e-04 | 86 | 184 | 6 | int:DPYSL3 | |
| Interaction | AGAP2 interactions | 1.38e-04 | 210 | 184 | 9 | int:AGAP2 | |
| Interaction | MTNR1A interactions | 1.47e-04 | 166 | 184 | 8 | int:MTNR1A | |
| Interaction | SYTL1 interactions | 1.55e-04 | 12 | 184 | 3 | int:SYTL1 | |
| Interaction | DPYS interactions | 1.55e-04 | 12 | 184 | 3 | int:DPYS | |
| Interaction | ITGA4 interactions | EPS15 MYH10 SRM CPA2 CCT4 SSRP1 HNRNPL LGALS8 GMPS FCGR2A TLN1 CD81 SNRPA1 RAB2A RAB5C | 1.57e-04 | 547 | 184 | 15 | int:ITGA4 |
| Interaction | ARHGAP24 interactions | MYH10 ABCF1 COPB1 FXR2 RDX CCT4 SSRP1 OPA1 GTF3C4 HNRNPL ZNF701 KIF2A FOXK1 SEC23A | 1.57e-04 | 486 | 184 | 14 | int:ARHGAP24 |
| Interaction | PARP1 interactions | NIBAN1 GAPVD1 MYH10 SPTA1 PSMD12 SSRP1 SRBD1 SRCAP TRRAP ZBTB24 HNRNPL RHEB GMPS IVNS1ABP ACE2 CDK13 FAM169A KIF2A CTNNA1 EEA1 DDX39A FMNL1 ZMYM4 SEC23A KIF22 KPNA3 | 1.64e-04 | 1316 | 184 | 26 | int:PARP1 |
| Interaction | SIRT7 interactions | TPP2 DPYSL2 GAPVD1 MYH10 ABCF1 COPB1 FXR2 USP24 PSMD12 TRRAP GMPS DST P4HB TLN1 MCM3AP MACF1 CTNNA1 SEC23A | 1.66e-04 | 744 | 184 | 18 | int:SIRT7 |
| Interaction | PLEC interactions | TET2 DNAH3 BMP2K KRT34 SPTA1 HNRNPL ACE2 DST MCM3AP PDE4DIP MACF1 FMNL1 FOXK1 | 1.69e-04 | 430 | 184 | 13 | int:PLEC |
| Interaction | YWHAZ interactions | TET2 DPYSL2 GAPVD1 MYH10 MYH11 PDE6C COPB1 SPTA1 PPFIA1 PSD3 ZNF395 TRIM3 HNRNPL RHEB IVNS1ABP FSIP2 ACE2 RMDN3 KSR1 IPO9 DST MACF1 AKAP11 KIF2A TAB1 FOXK1 | 1.70e-04 | 1319 | 184 | 26 | int:YWHAZ |
| Interaction | DYRK1A interactions | EPS15 DPYSL2 DPYSL3 MYH11 PPFIA1 DSCAML1 OPA1 HAUS8 BCAP31 TONSL AKAP11 CTNNA1 PALLD DKK3 SEC23A | 1.73e-04 | 552 | 184 | 15 | int:DYRK1A |
| Interaction | CDC42 interactions | FLOT2 DPYSL2 FAT4 MYH10 PDE6C SYNE1 PPFIA1 PSD3 SRM NCF2 PSMD12 CPT1A TRRAP LGALS8 ITPR2 IVNS1ABP BCAP31 IPO9 MCM3AP CTNNA1 RAB32 RAB2A PALLD GPAT4 FMNL1 RAB5C | 1.78e-04 | 1323 | 184 | 26 | int:CDC42 |
| Interaction | BRCA1 interactions | TPP2 GAPVD1 MYH10 COPB1 FXR2 PPFIA1 RDX CCT4 PSMD12 SSRP1 GTF3C4 HNRNPL GMPS DST P4HB TLN1 TONSL KIF2A CTNNA1 DDX39A PALLD SEC23A RAB5C KIF22 KPNA3 | 1.82e-04 | 1249 | 184 | 25 | int:BRCA1 |
| Interaction | WDR5 interactions | TET2 DPYSL2 ABCF1 COPB1 FXR2 RDX CCT4 PSMD12 SSRP1 TRRAP MEIS2 HNRNPL PDIA6 TRAP1 P4HB TLN1 MACF1 KIF2A GNAI3 CTNNA1 TAF10 SNRPA1 RAB5C | 1.82e-04 | 1101 | 184 | 23 | int:WDR5 |
| Interaction | TTLL6 interactions | 2.00e-04 | 13 | 184 | 3 | int:TTLL6 | |
| Interaction | RNF123 interactions | MYH4 DNAH3 DPYSL2 FAT4 GAPVD1 FXR2 ZC2HC1C DGKH DSCAML1 HNRNPL ITPR2 GMPS IVNS1ABP DST TLN1 MCM3AP GNAT3 POTEA PCDH10 | 2.02e-04 | 824 | 184 | 19 | int:RNF123 |
| Interaction | PHOSPHO1 interactions | 2.02e-04 | 59 | 184 | 5 | int:PHOSPHO1 | |
| Interaction | NBR1 interactions | FXR2 USP24 CCT4 PSMD12 TRRAP HNRNPL GMPS MTMR6 DST MACF1 GNAI3 RAB5C | 2.02e-04 | 380 | 184 | 12 | int:NBR1 |
| Interaction | TNIK interactions | DPYSL2 DPYSL3 FXR2 SYNE1 TRIM3 DST PDE4DIP MACF1 KIF2A CTNNA1 SEC23A SOS1 | 2.07e-04 | 381 | 184 | 12 | int:TNIK |
| Interaction | PPP1R9B interactions | TPP2 DLGAP2 MYH4 DPYSL2 DPYSL3 MYH10 MYH11 RDX CCT4 ZC2HC1C OPA1 HNRNPL CRMP1 SYNJ1 GNAI1 KIF2A | 2.10e-04 | 626 | 184 | 16 | int:PPP1R9B |
| Interaction | YWHAQ interactions | TET2 MYH11 PDE6C SPTA1 PPFIA1 PSD3 ZNF395 HNRNPL IVNS1ABP ACE2 RMDN3 KSR1 BCAP31 IPO9 DST P4HB TLN1 MACF1 AKAP11 GNAI3 TAB1 DDX39A FOXK1 | 2.27e-04 | 1118 | 184 | 23 | int:YWHAQ |
| Interaction | H2BC10 interactions | 2.36e-04 | 61 | 184 | 5 | int:H2BC10 | |
| Interaction | H2AC4 interactions | MICAL1 MYH10 COPB1 FXR2 ZNF395 SSRP1 MIDEAS GTF3C4 ACE2 IPO9 C16orf87 TONSL EEA1 KIF22 | 2.37e-04 | 506 | 184 | 14 | int:H2AC4 |
| Interaction | SEC62 interactions | B4GAT1 COPB1 SYNE1 ATL1 ITPR2 RMDN3 BCAP31 IPO9 P4HB TLN1 TOX3 FAM169A AKAP11 GPAT4 | 2.37e-04 | 506 | 184 | 14 | int:SEC62 |
| Interaction | CD99P1 interactions | 2.47e-04 | 3 | 184 | 2 | int:CD99P1 | |
| Interaction | H3-4 interactions | ABCF1 SPTA1 ZNF395 TRRAP GTF3C4 HNRNPL CDK13 TONSL CD81 KIF2A TAF10 ZMYM4 KIF22 | 2.52e-04 | 448 | 184 | 13 | int:H3-4 |
| Interaction | ROR2 interactions | FLOT2 B4GAT1 COPB1 RDX HNRNPL MTMR6 TAB1 DDX39A RAB2A ZMYM4 SEC23A | 2.54e-04 | 333 | 184 | 11 | int:ROR2 |
| Interaction | H2BC8 interactions | SSRP1 SRBD1 SRCAP MIDEAS TRRAP ZBTB24 GTF3C4 DNAJC17 IPO9 C16orf87 FAM169A AKAP11 ZMYM4 KIF22 KPNA3 | 2.73e-04 | 576 | 184 | 15 | int:H2BC8 |
| Interaction | SSR1 interactions | FLOT2 TRPV1 SYNE1 CCT4 ATL1 ITPR2 HSPA13 ACE2 BCAP31 TOX3 FAM169A GPAT4 RAB5C | 2.80e-04 | 453 | 184 | 13 | int:SSR1 |
| Interaction | EPB41L4A interactions | 3.05e-04 | 140 | 184 | 7 | int:EPB41L4A | |
| Interaction | PLEKHH1 interactions | 3.14e-04 | 15 | 184 | 3 | int:PLEKHH1 | |
| Interaction | SNCA interactions | TPP2 MYH10 ABCF1 COPB1 FXR2 USP24 RDX ATL1 RHEB GMPS DST CDK13 PDE4DIP MACF1 TLN2 KIF2A CTNNA1 | 3.15e-04 | 716 | 184 | 17 | int:SNCA |
| Interaction | CIT interactions | FLOT2 MYH10 MYH11 ABCF1 FBLL1 COPB1 FXR2 SYNE1 CCT4 APOB SSRP1 SRBD1 SLC7A7 TRRAP GTF3C4 HNRNPL SPTBN4 ACE2 PDIA6 TRAP1 P4HB MACF1 MAIP1 KIF2A CTNNA1 SPAG17 KPNA3 | 3.15e-04 | 1450 | 184 | 27 | int:CIT |
| Interaction | DUSP22 interactions | 3.19e-04 | 141 | 184 | 7 | int:DUSP22 | |
| Interaction | HSP90B1 interactions | APOB NCSTN SRBD1 TRRAP LGALS8 HSPA13 IVNS1ABP ACE2 RMDN3 PDIA6 BCAP31 IPO9 P4HB FMNL1 ZMYM4 KPNA3 | 3.19e-04 | 650 | 184 | 16 | int:HSP90B1 |
| Interaction | ITGB1 interactions | MYH10 RDX HNRNPL LGALS8 ACE2 BCAP31 CD36 TLN1 CD81 RAB2A RAB5C CDH17 | 3.23e-04 | 400 | 184 | 12 | int:ITGB1 |
| Interaction | RIN3 interactions | TPP2 CCT4 ZBTB24 HNRNPL GMPS IVNS1ABP PDIA6 BCAP31 P4HB TLN1 TLN2 RAB2A RAB5C | 3.45e-04 | 463 | 184 | 13 | int:RIN3 |
| Interaction | PTPRO interactions | 3.47e-04 | 143 | 184 | 7 | int:PTPRO | |
| Interaction | TULP3 interactions | DPH1 PPFIA1 HNRNPL ACE2 DST PDE4DIP TONSL TTC21B RAB2A FOXK1 RAB5C | 3.52e-04 | 346 | 184 | 11 | int:TULP3 |
| Interaction | DNAAF2 interactions | 3.67e-04 | 103 | 184 | 6 | int:DNAAF2 | |
| Interaction | ARMC1 interactions | 3.67e-04 | 67 | 184 | 5 | int:ARMC1 | |
| Interaction | HRH1 interactions | 3.84e-04 | 16 | 184 | 3 | int:HRH1 | |
| Interaction | HMGCS2 interactions | 3.84e-04 | 16 | 184 | 3 | int:HMGCS2 | |
| Interaction | SIGIRR interactions | 3.84e-04 | 16 | 184 | 3 | int:SIGIRR | |
| Interaction | CD99 interactions | 3.93e-04 | 68 | 184 | 5 | int:CD99 | |
| Interaction | PRKAG2 interactions | 3.93e-04 | 68 | 184 | 5 | int:PRKAG2 | |
| Interaction | LOXL2 interactions | MYH10 MYH11 ABCF1 COPB1 FXR2 CCT4 SSRP1 PI15 HNRNPL P4HB MACF1 EEA1 | 4.03e-04 | 410 | 184 | 12 | int:LOXL2 |
| Interaction | YAP1 interactions | FLOT2 DPYSL2 DPYSL3 GAPVD1 MYH10 MYH11 FBLL1 CCT4 SSRP1 SRCAP MIDEAS TRRAP GTF3C4 TRAP1 P4HB TLN1 GNAI1 GNAI3 TAB1 CTNNA1 PALLD ZMYM4 | 4.32e-04 | 1095 | 184 | 22 | int:YAP1 |
| Interaction | NR2C2 interactions | MYH10 ABCF1 COPB1 BMP2K FXR2 USP24 HLCS RDX CCT4 PSMD12 SSRP1 OPA1 HNRNPL RHEB GMPS TRAP1 IPO9 KIF2A TAB1 TAF10 SNRPA1 DDX39A RAB2A MRPL1 RAB5C KIF22 | 4.42e-04 | 1403 | 184 | 26 | int:NR2C2 |
| Interaction | NEUROG3 interactions | 4.45e-04 | 149 | 184 | 7 | int:NEUROG3 | |
| Interaction | TNIP2 interactions | FLOT2 MYH10 FXR2 COG7 KRT34 PPFIA1 TEX14 ECI1 CEP164 HNRNPL TRAP1 SERPINE2 P4HB RAB11FIP4 TAF10 PBX3 PCDH10 DKK3 SEC23A KPNA3 | 4.57e-04 | 952 | 184 | 20 | int:TNIP2 |
| Interaction | RHOF interactions | FLOT2 FAT4 PPFIA1 PSD3 RDX SSRP1 RHEB FAM169A MACF1 CTNNA1 RAB32 RAB2A GPAT4 FMNL1 RAB5C KIF22 | 4.67e-04 | 673 | 184 | 16 | int:RHOF |
| GeneFamily | Myosin heavy chains | 2.71e-06 | 15 | 124 | 4 | 1098 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.80e-04 | 50 | 124 | 4 | 1293 | |
| GeneFamily | EF-hand domain containing|Spectrins | 9.58e-04 | 7 | 124 | 2 | 1113 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.27e-03 | 8 | 124 | 2 | 939 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPS15 GAPVD1 BMP2K PPFIA1 USP24 PSD3 RDX TRRAP OPA1 MEIS2 GMPS DST CDK13 FAM169A LHFPL2 MACF1 AKAP11 GNAI1 KIF2A TNFAIP8 PBX3 ZMYM4 SOS1 KPNA3 | 1.06e-08 | 856 | 186 | 24 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | EPS15 GAPVD1 PPFIA1 USP24 TRRAP OPA1 MEIS2 GMPS DST CDK13 FAM169A LHFPL2 KIF2A PBX3 ZMYM4 SOS1 KPNA3 | 4.26e-08 | 466 | 186 | 17 | M13522 |
| Coexpression | TRAVAGLINI_LUNG_TREM2_DENDRITIC_CELL | ABCC3 DPYSL2 RDX NCF2 SLC7A7 RHEB RMDN3 PDIA6 BCAP31 DST FCGR2A LHFPL2 CD81 CTNNA1 RAB32 PALLD RAB5C | 7.65e-07 | 572 | 186 | 17 | M41698 |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | MYH10 ACAT2 RDX SSRP1 ECI1 LGALS8 GMPS IVNS1ABP PDIA6 TRAP1 BCAP31 SERPINE2 DNAJC17 THG1L GNAI1 SNRPA1 ESPL1 KIF22 | 1.48e-06 | 669 | 186 | 18 | M18635 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | EPS15 DPYSL2 MYH10 MYH11 COPB1 BMP2K TRRAP HSPA13 BCAP31 SERPINE2 DST CDK13 CTNNA1 RAB2A PALLD SEC23A | 3.26e-06 | 568 | 186 | 16 | M4023 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | EPS15 MICAL1 FLOT2 NIBAN1 GAPVD1 COPB1 SYNE1 USP24 PPM1M GBP2 GPRIN3 CCT4 RHEB ITPR2 IVNS1ABP CDK13 CD101 TLN1 PDE4DIP MACF1 AKAP11 CD81 KIF2A GNAI3 TNFAIP8 FMNL1 SOS1 | 7.26e-06 | 1492 | 186 | 27 | M40023 |
| Coexpression | GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP | 1.38e-05 | 200 | 186 | 9 | M363 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 1.38e-05 | 200 | 186 | 9 | M9889 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | EPS15 FLOT2 DPYSL2 TRPV1 COPB1 BMP2K CCT4 OPA1 ABCB4 ITPR2 HSPA13 RMDN3 PDIA6 CDK13 PDE4DIP LHFPL2 MACF1 GNAI3 CTNNA1 EEA1 PBX3 C1orf50 ZMYM4 | 1.83e-05 | 1215 | 186 | 23 | M41122 |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 2.46e-05 | 81 | 186 | 6 | M39253 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN | NIBAN1 MYH10 SYNE1 PSD3 RDX NCF2 SSRP1 OPA1 LGALS8 TTC21B KIF2A CTNNA1 | 3.04e-05 | 399 | 186 | 12 | M40939 |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 3.46e-05 | 86 | 186 | 6 | M39247 | |
| Coexpression | RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP | MICAL1 DPYSL2 NIBAN1 PSD3 RDX BCAP31 PDE4DIP LHFPL2 CD81 KIF2A TNFAIP8 | 3.48e-05 | 341 | 186 | 11 | M12636 |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN | DPYSL3 ADAMTS2 LGALS8 HSPA13 MTMR6 BCAP31 SERPINE2 P4HB TLN1 CD81 RAB32 RAB5C | 3.68e-05 | 407 | 186 | 12 | M19541 |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_2HR_DN | 4.20e-05 | 89 | 186 | 6 | M8916 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | TPP2 MICAL1 RDX TRRAP MEIS2 LGALS8 ITPR2 IPO9 MCM3AP PDE4DIP LHFPL2 MACF1 TNFAIP8 SNRPA1 DDX39A RAB2A SOS1 | 5.17e-05 | 790 | 186 | 17 | M12490 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBM | MICAL1 DPYSL3 DPYSL4 DSCAML1 ATL1 CRMP1 PDE4DIP TOX3 RAB11FIP4 PBX3 | 5.25e-05 | 295 | 186 | 10 | M39063 |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | DLGAP2 DPYSL2 PSD3 APOB PSMD12 ECI1 SERPINE2 FCGR2A MACF1 ESPL1 DDX39A | 7.60e-05 | 372 | 186 | 11 | M19261 |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 7.74e-05 | 194 | 186 | 8 | M2517 | |
| Coexpression | GSE3982_MAST_CELL_VS_MAC_DN | 8.02e-05 | 195 | 186 | 8 | M5431 | |
| Coexpression | GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN | 8.20e-05 | 145 | 186 | 7 | M359 | |
| Coexpression | CAMP_UP.V1_DN | 9.24e-05 | 199 | 186 | 8 | M2719 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_UP | 9.57e-05 | 200 | 186 | 8 | M9381 | |
| Coexpression | GSE3039_CD4_TCELL_VS_B1_BCELL_UP | 9.57e-05 | 200 | 186 | 8 | M6466 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CELF6 DPYSL3 FBLL1 GPRIN3 DSCAML1 RYR2 ATL1 CRMP1 FSIP2 MTMR6 SYNJ1 PDE4DIP TOX3 FAM169A TLN2 RAB11FIP4 EEA1 SPAG17 PBX3 ZNF471 | 1.24e-04 | 1106 | 186 | 20 | M39071 |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 1.34e-04 | 210 | 186 | 8 | MM958 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN | MYH10 MYH11 RDX ECI1 SLC7A7 HSPA13 DST TOX3 FAM169A AKAP11 CTNNA1 RAB2A SEC23A | 1.72e-04 | 553 | 186 | 13 | M1475 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | DPYSL3 GAPVD1 LRRN1 COG7 SPTA1 KIAA0586 RDX DPYSL4 GBP2 SRCAP MEIS2 CRMP1 HSPA13 GMPS ALDH1A2 TOX3 THG1L LHFPL2 GNAI3 CPLANE1 RAB32 | 7.82e-06 | 815 | 183 | 21 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | EPS15 GAPVD1 LRRN1 COG7 KIAA0586 GBP2 CPA2 TEX14 SRCAP MEIS2 RYR2 GMPS ACE2 ALDH1A2 THG1L FAM169A LHFPL2 GNAI3 CPLANE1 RAB32 | 2.16e-05 | 804 | 183 | 20 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | TPP2 DPYSL2 FAT4 NIBAN1 DPYSL3 MYH11 LRRN1 CRMP1 HSPA13 TMEM132C ALDH1A2 DST TOX3 CXXC4 TLN2 GNAI1 CPLANE1 PCDH10 DKK3 ZMYM4 | 2.24e-05 | 806 | 183 | 20 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | TPP2 MICAL1 NIBAN1 MYH11 LRRN1 ADAMTS2 NXNL2 OPA1 MEIS2 RYR2 TMEM132C PDIA6 ALDH1A2 IPO9 BBS7 CD36 LHFPL2 GNAI1 DKK3 KIF22 | 3.81e-05 | 837 | 183 | 20 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | FAT4 DPYSL3 MYH10 ADAMTS2 LAMA2 RYR2 TMEM132C DST TLN2 PALLD DKK3 | 4.32e-10 | 187 | 186 | 11 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.40e-09 | 191 | 186 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.74e-09 | 194 | 186 | 10 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | NIBAN1 MYH10 MYH11 ADAMTS2 TMEM132C SERPINE2 P4HB LHFPL2 PALLD DKK3 | 1.02e-08 | 195 | 186 | 10 | 2514c1f23424b5fc664d326d31ffd22bafe74ef8 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-08 | 197 | 186 | 10 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | PND14-Mesenchymal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | NIBAN1 MYH10 MYH11 ADAMTS2 PI15 TMEM132C SERPINE2 CD81 PALLD DKK3 | 1.13e-08 | 197 | 186 | 10 | 9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.24e-08 | 199 | 186 | 10 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.24e-08 | 199 | 186 | 10 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.30e-08 | 200 | 186 | 10 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.30e-08 | 200 | 186 | 10 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.54e-08 | 175 | 186 | 9 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-08 | 181 | 186 | 9 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-07 | 190 | 186 | 9 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-07 | 190 | 186 | 9 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-07 | 190 | 186 | 9 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-07 | 192 | 186 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.28e-07 | 193 | 186 | 9 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.28e-07 | 193 | 186 | 9 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-07 | 193 | 186 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-07 | 193 | 186 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.28e-07 | 193 | 186 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.34e-07 | 194 | 186 | 9 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-07 | 196 | 186 | 9 | e4d04e1f82779e8afd4e32bbe38d1d3f6f64ab50 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-07 | 196 | 186 | 9 | f0fd7db22985d2bc84dc8bcbdb2d552e280121dd | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | NIBAN1 MYH10 MYH11 ADAMTS2 TMEM132C SERPINE2 LHFPL2 PALLD DKK3 | 1.52e-07 | 197 | 186 | 9 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | NIBAN1 MYH10 MYH11 ADAMTS2 TMEM132C SERPINE2 LHFPL2 PALLD DKK3 | 1.52e-07 | 197 | 186 | 9 | 155e63b33302a87393ace699b2f6d73abe9c5763 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-07 | 197 | 186 | 9 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | P07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | NIBAN1 MYH10 MYH11 ADAMTS2 TMEM132C SERPINE2 LHFPL2 PALLD DKK3 | 1.52e-07 | 197 | 186 | 9 | b1135378d768fbbe62a75747d1e8653d35252187 |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-07 | 197 | 186 | 9 | 8c728cd3c0382c4f3e4b78647b6e1447bb40ace1 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.52e-07 | 197 | 186 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | NIBAN1 MYH10 ADAMTS2 TMEM132C SERPINE2 LHFPL2 CD81 PALLD DKK3 | 1.59e-07 | 198 | 186 | 9 | ce59ee3d970397eb62d6387699c6c6cd65457898 |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | NIBAN1 MYH10 MYH11 ADAMTS2 TMEM132C SERPINE2 LHFPL2 PALLD DKK3 | 1.59e-07 | 198 | 186 | 9 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-07 | 198 | 186 | 9 | 0993d6895c0e4f360998ce35abea4ec3dd13e048 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-07 | 198 | 186 | 9 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.66e-07 | 199 | 186 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.66e-07 | 199 | 186 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.73e-07 | 200 | 186 | 9 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.73e-07 | 200 | 186 | 9 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.73e-07 | 200 | 186 | 9 | 6dd89835a9f7bebb4849cff8eecb82caf6e1acbf | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.73e-07 | 200 | 186 | 9 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.73e-07 | 200 | 186 | 9 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.73e-07 | 200 | 186 | 9 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.73e-07 | 200 | 186 | 9 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.73e-07 | 200 | 186 | 9 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.11e-07 | 148 | 186 | 8 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.24e-07 | 174 | 186 | 8 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-06 | 127 | 186 | 7 | fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 184 | 186 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 184 | 186 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.10e-06 | 184 | 186 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 184 | 186 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.24e-06 | 187 | 186 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | P15-Mesenchymal|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.30e-06 | 188 | 186 | 8 | f1ba0b661621a65c91432e62ba73531bdf18e7c1 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 189 | 186 | 8 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 189 | 186 | 8 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 189 | 186 | 8 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.35e-06 | 189 | 186 | 8 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 189 | 186 | 8 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.40e-06 | 190 | 186 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.46e-06 | 191 | 186 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-06 | 193 | 186 | 8 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-06 | 193 | 186 | 8 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-06 | 193 | 186 | 8 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-06 | 193 | 186 | 8 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-06 | 194 | 186 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-06 | 194 | 186 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.70e-06 | 195 | 186 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.70e-06 | 195 | 186 | 8 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.70e-06 | 195 | 186 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 196 | 186 | 8 | 14246f00c90741a5f8683f377e22e3a7c99661b9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-06 | 196 | 186 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-06 | 196 | 186 | 8 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 196 | 186 | 8 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.77e-06 | 196 | 186 | 8 | 80264c2fbd94418f981085fed7c5bdda1e6f404c | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 196 | 186 | 8 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 196 | 186 | 8 | 2a885eed52f9b002c7995e11e450c7e8d7ae69e6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-06 | 196 | 186 | 8 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | PND07-Mesenchymal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 196 | 186 | 8 | 0050c7134473fbfd7b9f0ae8d6d337713e60b57d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-06 | 196 | 186 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | P07-Mesenchymal-myocytic_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.84e-06 | 197 | 186 | 8 | 378299fe2ec6ed2fc858febb78ff1ac0898e457d | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-06 | 197 | 186 | 8 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.84e-06 | 197 | 186 | 8 | 4f7c10a636646dfc82a84026c1b5a36603367abe | |
| ToppCell | MatrixFB|World / shred on cell class and cell subclass (v4) | 1.84e-06 | 197 | 186 | 8 | e325de44e32021a36fffb7b7e88167b46bb051c7 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-06 | 198 | 186 | 8 | 93cc01d91ffc543fd1a717ef47e02e532b50b665 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.91e-06 | 198 | 186 | 8 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.91e-06 | 198 | 186 | 8 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-06 | 198 | 186 | 8 | 3ffaea4b44067d69f954b2bd3119c88a55ab232a | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-06 | 198 | 186 | 8 | b2d295e330772bd8e24da356c75564b4297ea9c5 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.91e-06 | 198 | 186 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.91e-06 | 198 | 186 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | E18.5-Mesenchymal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-06 | 198 | 186 | 8 | a16aa41eab2e297e56de43c22c355df0f79315da | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Alveolar_macrophages|Lung / Manually curated celltypes from each tissue | 1.98e-06 | 199 | 186 | 8 | eec1b086e5e8b9b0e1770dd269ca903f713d99a8 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.98e-06 | 199 | 186 | 8 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 1.98e-06 | 199 | 186 | 8 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 1.98e-06 | 199 | 186 | 8 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 1.98e-06 | 199 | 186 | 8 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac|Lung / Manually curated celltypes from each tissue | 1.98e-06 | 199 | 186 | 8 | 1677aaee5b7f5f262e27df5d9f1bdf6e21e3d804 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.98e-06 | 199 | 186 | 8 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | E16.5-Mesenchymal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-06 | 199 | 186 | 8 | ebd9ca151434f5ca27a82d4f1815a1ea500c1989 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.98e-06 | 199 | 186 | 8 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 1.00e-07 | 8 | 184 | 4 | DOID:1858 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | TET2 ABCC3 DNAH3 DPYSL2 SYNE1 FRMPD2 APOB TLR9 DSCAML1 RHEB ABCB4 MCM3AP SPAG17 ZNF471 ZMYM4 RAB5C | 9.27e-06 | 702 | 184 | 16 | C0009402 |
| Disease | achromatopsia (implicated_via_orthology) | 3.87e-05 | 2 | 184 | 2 | DOID:13911 (implicated_via_orthology) | |
| Disease | apolipoprotein A 1 measurement | TET2 PSD3 RDX APOB CPT1A MIDEAS CEP164 RNF214 ALDH1A2 CD36 MACF1 NDUFAF6 TNFAIP8 RAB11FIP4 FOXK1 CDH17 | 8.92e-05 | 848 | 184 | 16 | EFO_0004614 |
| Disease | proprotein convertase subtilisin/kexin type 7 measurement | 1.52e-04 | 17 | 184 | 3 | EFO_0008270 | |
| Disease | Progressive cone dystrophy (without rod involvement) | 2.30e-04 | 4 | 184 | 2 | C0271092 | |
| Disease | exercise test | 2.52e-04 | 20 | 184 | 3 | EFO_0004328 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 2.69e-04 | 50 | 184 | 4 | EFO_0022303 | |
| Disease | vitamin D measurement | 2.77e-04 | 336 | 184 | 9 | EFO_0004631 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 2.91e-04 | 51 | 184 | 4 | EFO_0022285 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 2.92e-04 | 21 | 184 | 3 | EFO_0022262 | |
| Disease | Degenerative polyarthritis | 2.98e-04 | 93 | 184 | 5 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 2.98e-04 | 93 | 184 | 5 | C0086743 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 3.82e-04 | 5 | 184 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | JOUBERT SYNDROME 17 | 3.82e-04 | 5 | 184 | 2 | C3553264 | |
| Disease | seasonality measurement, vitamin D measurement | 3.82e-04 | 5 | 184 | 2 | EFO_0004631, EFO_0006876 | |
| Disease | level of Phosphatidylcholine (O-16:0_16:1) in blood serum | 3.82e-04 | 5 | 184 | 2 | OBA_2045112 | |
| Disease | Achromatopsia | 3.82e-04 | 5 | 184 | 2 | cv:C0152200 | |
| Disease | Color Blindness, Blue | 5.71e-04 | 6 | 184 | 2 | C0155017 | |
| Disease | mean corpuscular hemoglobin concentration | ADGRG5 FLOT2 CUX2 BMP2K SPTA1 PSD3 MIDEAS ITPR2 HAUS8 ALDH1A2 BBS7 CD36 UGT2A3 THG1L MACF1 KIF2A DDX39A | 5.85e-04 | 1105 | 184 | 17 | EFO_0004528 |
| Disease | Achromatopsia | 7.96e-04 | 7 | 184 | 2 | C0152200 | |
| Disease | Polydactyly | 8.51e-04 | 117 | 184 | 5 | C0152427 | |
| Disease | esophageal adenocarcinoma, Barrett's esophagus | 9.43e-04 | 31 | 184 | 3 | EFO_0000280, EFO_0000478 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 1.06e-03 | 8 | 184 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 1.13e-03 | 33 | 184 | 3 | DOID:9452 (biomarker_via_orthology) | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.20e-03 | 74 | 184 | 4 | EFO_0022280 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.23e-03 | 127 | 184 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | asparaginase-induced acute pancreatitis | 1.35e-03 | 9 | 184 | 2 | EFO_1001507 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 1.46e-03 | 78 | 184 | 4 | EFO_0022187 | |
| Disease | cancer (implicated_via_orthology) | 1.52e-03 | 268 | 184 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | degree of unsaturation measurement | 1.85e-03 | 39 | 184 | 3 | EFO_0022261 | |
| Disease | docosahexaenoic acid measurement, fatty acid measurement | 1.99e-03 | 40 | 184 | 3 | EFO_0005110, EFO_0007761 | |
| Disease | Intellectual Disability | 2.06e-03 | 447 | 184 | 9 | C3714756 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.09e-03 | 86 | 184 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | carotid artery intima media thickness | 2.16e-03 | 450 | 184 | 9 | EFO_0007117 | |
| Disease | Disorder of eye | 2.21e-03 | 212 | 184 | 6 | C0015397 | |
| Disease | beta-nerve growth factor measurement | 2.29e-03 | 42 | 184 | 3 | EFO_0008035 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.42e-03 | 291 | 184 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 2.45e-03 | 43 | 184 | 3 | EFO_0022290 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.55e-03 | 150 | 184 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | hepatocyte growth factor measurement | 2.62e-03 | 44 | 184 | 3 | EFO_0006903 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.77e-03 | 222 | 184 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | saturated fatty acids measurement | 2.79e-03 | 45 | 184 | 3 | EFO_0022304 | |
| Disease | Short Rib-Polydactyly Syndrome | 2.88e-03 | 13 | 184 | 2 | C0036996 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.96e-03 | 225 | 184 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 3.00e-03 | 95 | 184 | 4 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | hypertension (biomarker_via_orthology) | 3.10e-03 | 227 | 184 | 6 | DOID:10763 (biomarker_via_orthology) | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.11e-03 | 96 | 184 | 4 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | lysophosphatidylcholine 15:0 measurement | 3.35e-03 | 14 | 184 | 2 | EFO_0020941 | |
| Disease | Saldino-Noonan Syndrome | 3.35e-03 | 14 | 184 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 3.35e-03 | 14 | 184 | 2 | C0024507 | |
| Disease | vitamin D measurement, COVID-19 | 3.56e-03 | 49 | 184 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | amino acid measurement | DLGAP2 FAT4 MYH10 LRRN1 COG7 SYNE1 PSD3 MEIS2 RYR2 GNAI1 MCOLN2 | 3.68e-03 | 678 | 184 | 11 | EFO_0005134 |
| Disease | cholesteryl esters to total lipids in IDL percentage | 3.77e-03 | 50 | 184 | 3 | EFO_0022247 | |
| Disease | Down syndrome (implicated_via_orthology) | 3.85e-03 | 15 | 184 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | low density lipoprotein triglyceride measurement | 3.85e-03 | 15 | 184 | 2 | EFO_0009946 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 3.85e-03 | 15 | 184 | 2 | EFO_0022328 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 3.99e-03 | 51 | 184 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 3.99e-03 | 51 | 184 | 3 | EFO_0022240 | |
| Disease | sleep duration, triglyceride measurement | 4.14e-03 | 104 | 184 | 4 | EFO_0004530, EFO_0005271 | |
| Disease | intracerebral hemorrhage | 4.38e-03 | 16 | 184 | 2 | EFO_0005669 | |
| Disease | vision disorder | 4.38e-03 | 16 | 184 | 2 | MONDO_0021084 | |
| Disease | Malaria, susceptibility to | 4.38e-03 | 16 | 184 | 2 | cv:C1970028 | |
| Disease | – | 4.38e-03 | 16 | 184 | 2 | 611162 | |
| Disease | 4-acetamidobutanoate measurement | 4.38e-03 | 16 | 184 | 2 | EFO_0021003 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 4.44e-03 | 53 | 184 | 3 | EFO_0022340 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 4.44e-03 | 53 | 184 | 3 | EFO_0022286 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 4.44e-03 | 53 | 184 | 3 | EFO_0022258 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 4.69e-03 | 54 | 184 | 3 | EFO_0022244 | |
| Disease | alkaline phosphatase measurement | TET2 CUX2 ADAMTS2 PSD3 APOB CPT1A ECI1 CRMP1 ALDH1A2 CD36 TONSL MACF1 OTUD3 TAB1 | 4.73e-03 | 1015 | 184 | 14 | EFO_0004533 |
| Disease | triglycerides in very large HDL measurement | 4.93e-03 | 55 | 184 | 3 | EFO_0022324 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 4.95e-03 | 17 | 184 | 2 | C1839839 | |
| Disease | Tactile Amnesia | 4.95e-03 | 17 | 184 | 2 | C0750906 | |
| Disease | Amnestic State | 4.95e-03 | 17 | 184 | 2 | C0750907 | |
| Disease | Dissociative Amnesia | 4.95e-03 | 17 | 184 | 2 | C0236795 | |
| Disease | muscular dystrophy (is_implicated_in) | 4.95e-03 | 17 | 184 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Hysterical amnesia | 4.95e-03 | 17 | 184 | 2 | C0233750 | |
| Disease | Temporary Amnesia | 4.95e-03 | 17 | 184 | 2 | C0233796 | |
| Disease | Amnesia | 4.95e-03 | 17 | 184 | 2 | C0002622 | |
| Disease | Global Amnesia | 4.95e-03 | 17 | 184 | 2 | C0262497 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 4.95e-03 | 17 | 184 | 2 | EFO_0022232 | |
| Disease | dermatomyositis (is_marker_for) | 4.95e-03 | 17 | 184 | 2 | DOID:10223 (is_marker_for) | |
| Disease | Ciliopathies | 5.06e-03 | 110 | 184 | 4 | C4277690 | |
| Disease | triglycerides in LDL measurement | 5.19e-03 | 56 | 184 | 3 | EFO_0022320 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 5.19e-03 | 56 | 184 | 3 | EFO_0022316 | |
| Disease | lipoprotein A measurement | 5.39e-03 | 112 | 184 | 4 | EFO_0006925 | |
| Disease | lupus nephritis (is_implicated_in) | 5.54e-03 | 18 | 184 | 2 | DOID:0080162 (is_implicated_in) | |
| Disease | serum hepcidin measurement | 5.54e-03 | 18 | 184 | 2 | EFO_0004504 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 5.54e-03 | 18 | 184 | 2 | OBA_2045175 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 5.54e-03 | 18 | 184 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | infant grey matter volume measurement | 5.54e-03 | 18 | 184 | 2 | EFO_0008368 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 5.66e-03 | 181 | 184 | 5 | DOID:684 (is_implicated_in) | |
| Disease | triglycerides in IDL measurement | 5.72e-03 | 58 | 184 | 3 | EFO_0022149 | |
| Disease | triglycerides to total lipids in small LDL percentage | 6.00e-03 | 59 | 184 | 3 | EFO_0022337 | |
| Disease | cerebral infarction (is_marker_for) | 6.17e-03 | 19 | 184 | 2 | DOID:3526 (is_marker_for) | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 6.17e-03 | 19 | 184 | 2 | OBA_2045199 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 6.17e-03 | 19 | 184 | 2 | EFO_0802076 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QALNTFTEIAASEKE | 1141 | Q7Z4L5 | |
| SFAQFQAEKQAVLAE | 371 | P24298 | |
| VASLKAANAAENDFS | 271 | Q8NE71 | |
| DLLDVDKNSAVVSFS | 416 | Q8IWZ6 | |
| EIVNALNSAAADDSK | 316 | Q9Y6F8 | |
| QIVAAFTSQAVDQSK | 191 | P83436 | |
| SVSVFAATKEEAQLA | 121 | O43505 | |
| VAAVFTNDINKALTV | 446 | O94788 | |
| AITFVSDENDAKILN | 386 | O00148 | |
| DENQFVAVTSTNAAK | 376 | Q14195 | |
| ISANSTDPVKAAQFE | 246 | P12318 | |
| FSEEVNIKTAEAQLA | 226 | Q14254 | |
| VNASDADASKNAVIR | 2386 | Q6V0I7 | |
| LTSNFAKSVVNLADV | 261 | O75078 | |
| QSLDAVEKAAFFVTL | 406 | P50416 | |
| ANFLVSEALSNALKD | 616 | Q9UKA4 | |
| FDELSEVAQKAAQSL | 326 | P48052 | |
| FKRSNSVTAAVQADL | 766 | Q9P1A6 | |
| FQAEVVALSKRSQEA | 71 | O14529 | |
| FVSTLQAAAQELKAE | 186 | Q9BZG8 | |
| ANRSVADKEAIANFT | 596 | Q9NSY1 | |
| VDDDANNAKAVVKTF | 136 | P60033 | |
| ETDAAQAAVQSAFAV | 1171 | Q14004 | |
| AVVSAKVFVDRATNQ | 421 | Q96J87 | |
| NEENDVDASSKTFIA | 776 | O95450 | |
| KTASNVEEAFINTAK | 151 | P61019 | |
| FETSAKDNINIEEAA | 171 | Q13637 | |
| ADLASKRAVEFQEAQ | 136 | P51148 | |
| AQTKAQSLAAEIDTA | 581 | Q86YS3 | |
| ATDTKNVQFVFDAVT | 326 | P63096 | |
| DLDFANDANKVLATT | 441 | Q14571 | |
| NVLDAEKAFVSVSLF | 561 | O15438 | |
| SFVTQLAAAEALQKA | 301 | Q92542 | |
| DLNFVTDTAKALADV | 476 | Q92542 | |
| QTKSNLFEAFVALAV | 56 | Q8WWG1 | |
| AEEAKSAIAKQAADQ | 396 | P35241 | |
| QEEANLYAAKTAVTA | 301 | P40426 | |
| DVDADFKAQNVTLEA | 61 | O00505 | |
| ATDTQNVKFVFDAVT | 326 | A8MTJ3 | |
| KNALAANIDEIVFTS | 191 | Q8WWC4 | |
| KATVVASVVDQDSFS | 201 | P19878 | |
| TSKQLAAAFQEEFTV | 221 | P51116 | |
| ATDTKNVQFVFDAVT | 326 | P08754 | |
| DENFIESSVAKLNAL | 11 | Q9Y6Y0 | |
| EFIRAKTNAANLSDA | 1256 | Q86VF7 | |
| EVNANAKSFNVDLLA | 206 | O00214 | |
| DAAIFLAKAITVENA | 316 | Q9Y217 | |
| DENQFVAVTSTNAAK | 376 | Q16555 | |
| SAQALAEVVKNTENF | 3696 | Q03001 | |
| SDSFNEDIAVFAKQV | 116 | O14770 | |
| EVKFAVQAFAALNSN | 836 | O60318 | |
| TAADDKTAQVEDFLQ | 1276 | Q14C86 | |
| ASNEAFKKQAESASE | 131 | P51572 | |
| TVQNLVFSKADQSEV | 266 | P50747 | |
| FTTSEILVADNFDKN | 4996 | Q5CZC0 | |
| SAEAVFASEVRKLQQ | 286 | A6NHQ2 | |
| IAESLKENAFNISAF | 516 | Q8IVT5 | |
| VSALNFAARSKEVIN | 356 | Q14807 | |
| LAQVAANATKEFTEA | 361 | Q96PD5 | |
| AVNKVNASEFSKQDE | 196 | P51160 | |
| RAFNVELAQVKDSVS | 91 | Q330K2 | |
| DFANIKANVKVASTE | 781 | P53618 | |
| FSAQAEIATSSDKVQ | 201 | Q6ZUX7 | |
| VLANVAQAFESDADV | 586 | Q13136 | |
| DSDVEQALQTFAKTS | 886 | Q8TDZ2 | |
| ALAQIENSAAVEKAI | 316 | P32456 | |
| DIVTVANAVFVKNAS | 106 | P07093 | |
| LDEAKNISFNATAAF | 1911 | P24043 | |
| SDSAKQFLQAAEAID | 166 | P07237 | |
| VDESEAFLSNLVVNK | 386 | O00232 | |
| NSSAFQEADIVSSKD | 896 | Q9P2E7 | |
| DKTLENAVVADAVAS | 531 | Q86XP1 | |
| ASVKDFNKSQAIESV | 216 | Q9H4K1 | |
| SFAQVLELSAEASKE | 311 | Q9BT25 | |
| DFASTLKVLEAQANT | 2681 | Q9UPN3 | |
| ETVKAQAESNKAFLA | 4501 | Q9UPN3 | |
| VSQDEIVSAAKAANI | 1146 | P21439 | |
| AEANTQVTLVKTFAA | 381 | Q5T2D3 | |
| QNSFSLELVVAAKEA | 1216 | Q8WX93 | |
| LESSAKENQTAVDVF | 146 | Q15382 | |
| VRESVEQQADSFKAT | 556 | O60313 | |
| KANEQADLLVSSAFI | 576 | Q9QC07 | |
| VKSFRAALQEEEQAS | 681 | O00139 | |
| DTSANILVDFAINAF | 191 | Q8NGY6 | |
| DENEFVAVTSTNAAK | 376 | O14531 | |
| FEQKAAQLATEIADI | 161 | Q15075 | |
| DADVQNFVSFISKDS | 271 | P42126 | |
| AALDLNAVANKIADF | 3836 | P04114 | |
| SNIAFNLAADAAQSK | 731 | Q14674 | |
| VKDFQVNITADSLFA | 281 | Q93033 | |
| ETNNILKIVADFSAS | 461 | P49915 | |
| TAEANNLAAVATAKD | 351 | Q8WXF7 | |
| LAASVEQATENFLEK | 61 | P35221 | |
| ANLSDEKAFVFSVAL | 126 | Q6PH81 | |
| KFLQAEETINENAAD | 491 | Q9H799 | |
| STVFLFADNQIKDES | 2486 | Q8TD57 | |
| DEDAVQFANRVKSAI | 396 | Q86UL3 | |
| KAQTAQDFAIIALED | 391 | Q8TD84 | |
| EADNFTVLNLAVAAA | 131 | P16671 | |
| AVFNAVTSFANLEEL | 366 | Q68DX3 | |
| AAVTDSAFQIANLAD | 96 | Q9H2H0 | |
| NVTSDLQLAAEFAAK | 271 | P85037 | |
| LQLAAEFAAKAASEQ | 276 | P85037 | |
| EFAAKAASEQQADTS | 281 | P85037 | |
| AAQSTIEEQAKTFLD | 16 | Q9BYF1 | |
| FATVKAAELAVQNEV | 221 | Q9NVM6 | |
| QLDQFTQSAEKAVDS | 621 | Q9Y6X4 | |
| AAVKATQTLQANESA | 966 | Q6PJG2 | |
| LLADSKTAQEAFESV | 956 | O95466 | |
| VEFDSVQSAQRAKAS | 236 | P14866 | |
| LLAVATDFQNESAAA | 406 | Q96P70 | |
| KFAEALITFVSDNSV | 186 | Q8WWI5 | |
| AEFDLKQRNSTIEAA | 176 | P48723 | |
| VADFSAIKELDTLNN | 326 | P42566 | |
| AAAAESTAFQRENKL | 396 | Q6ZVF9 | |
| VANASANATADFEQL | 71 | Q6ZMB0 | |
| FETAAVSNIVFKAEN | 521 | Q12864 | |
| VAFSDDFVAKLQDNQ | 1926 | Q92736 | |
| EAAAKASSEVNLANL | 76 | Q9UBP4 | |
| ADEFIRANATNKLTV | 66 | Q9BV19 | |
| DENQFVAVTSTNAAK | 376 | Q14194 | |
| SNQLVVAFKEDNTVA | 86 | Q8IZK6 | |
| AQTKEQADFAVEALA | 411 | P35580 | |
| FAKDAASLESQLQDT | 1306 | P35580 | |
| VPSDFAFANNVDKTV | 221 | A6NJI9 | |
| NVTTKNAAFAVDISD | 611 | Q6UXK5 | |
| KLAAVDATVNQVLAS | 216 | Q15084 | |
| DFNDSASLSKIQDAV | 451 | Q6S8J7 | |
| ALKAVAAQQQESATT | 226 | P03999 | |
| SATVEDALQSFLKAE | 396 | Q96TC7 | |
| SLAAQKFISDIANDA | 156 | Q12962 | |
| EAFQASSDTLVAVEK | 1046 | Q8IWB6 | |
| DALQNAKALESAAVS | 1911 | Q8NF91 | |
| KQQVDASAASAIQSD | 7311 | Q8NF91 | |
| KDFSLAATSQDEAVV | 731 | Q8N3T6 | |
| EFAKQTSLDAVAQAV | 316 | Q15750 | |
| NFFDSSKQEAIDVLL | 466 | O43426 | |
| VEAIKNAIANASTLA | 201 | P09661 | |
| VNIDNAKLASDDFRS | 171 | O76011 | |
| AEALAAVDIVSQSKS | 111 | Q12837 | |
| ATDTQNVKFVFDAVT | 326 | P19087 | |
| AQIRFSNISAAKAVA | 31 | P50991 | |
| AEEAEEQSNVNLAKF | 1886 | Q9Y623 | |
| AATQAKAEQVAELAE | 2256 | Q6ZRS2 | |
| VATDVFNSKNLAVQA | 11 | O95379 | |
| FQADIAENALKNSSE | 116 | Q5TEU4 | |
| VSNSKLFSANDVENI | 231 | Q07889 | |
| ENSVIFSAKSAEEKN | 521 | Q07889 | |
| QVQDVVLKDEFSSFS | 11 | Q8N5C6 | |
| QNIAASFDQEAAAIL | 511 | Q15436 | |
| SFTKKNEDANETAVQ | 1936 | Q6Q759 | |
| FAQNVLSKADVIQAT | 181 | Q08945 | |
| EAEAKAQIEAFSSSQ | 511 | Q8IZF4 | |
| ATLSAAIVQEKAEFD | 106 | B2RD01 | |
| ASEKSEQAALNAAKE | 731 | Q9UPV0 | |
| AQTKEQADFAVEALA | 411 | P35749 | |
| QNIAVQTDFKTADSE | 201 | Q8ND24 | |
| ASEINKVAVFTENAS | 151 | Q9BYD6 | |
| ATVEAEAALQNKVVA | 16 | Q5VZ03 | |
| AAQATASVNAEEIKV | 871 | Q9BZQ8 | |
| NEAFAAVSAAIVKEL | 321 | Q9BWD1 | |
| KAQVVSNDLQTFSEV | 1081 | A0A1B0GUW6 | |
| ALVEVADNTADNTKF | 291 | Q8NER1 | |
| DAFVVFDKTQSAVAD | 871 | Q9NR96 | |
| TLAADKNEILFSEFN | 211 | Q9NWX6 | |
| QATSDLVNAIKADAE | 831 | Q9Y490 | |
| ASDNLVKAAQKAAAF | 2466 | Q9Y490 | |
| LQAQAAFEKSLAIVD | 131 | Q96HA7 | |
| IINAEKSEFNEDQAA | 76 | Q96MI6 | |
| LASDAVAVTFADQIF | 291 | Q9UM01 | |
| ALENTAVKADNIEVF | 481 | P29144 | |
| VQLKEESAAAAAAAA | 326 | Q9H8N7 | |
| LFEASKADQLVQSFA | 1406 | Q9H254 | |
| KQNQDAFDVIITDSS | 161 | P19623 | |
| IKSSDEIENAFQALA | 2351 | P02549 | |
| LVSKAAAESAEAQTI | 326 | O15405 | |
| QFVTLKTFEEAAAQL | 511 | Q9UKN8 | |
| AAETAQARAASLEKN | 566 | Q9H6N6 | |
| TVLAATQAEKAVANF | 191 | Q53FD0 | |
| ASEKSTEQILATAQF | 101 | O43167 | |
| QDLVTFKDVAIDFSQ | 11 | Q9BX82 | |
| KAFLDALQNQAEASS | 181 | Q12931 | |
| IIAAAAVKFNSDQLN | 496 | Q9UPU5 | |
| TNSAFQAESKVAIVS | 586 | Q6PF04 | |
| EVAAKQAAAAATQTI | 921 | Q9Y4G6 | |
| FQNVTEEKANIIASA | 311 | Q6UWM9 | |
| NFTDIEAALKAQLDS | 36 | O43692 | |
| EKAINDAFSVSASQR | 231 | Q9NV72 | |
| TAEAFVNSKNAPAAE | 476 | Q5QJ38 | |
| VSSVAQENAVKDFTS | 151 | Q6N021 | |
| QATKVLDQDAVSSFS | 151 | Q9NYI0 | |
| SLAVQLFAKNIDDES | 396 | Q9Y4A5 | |
| QINKSEEANKAFSAA | 3131 | Q9Y4A5 | |
| SSFFDKAANQVEETL | 196 | Q5VZL5 | |
| SNAVQEADSELKQFS | 1116 | Q5VZL5 | |
| ADAILSFAKQNQESA | 1291 | Q9BVV6 | |
| QERKAEALAQISAAF | 191 | O75382 | |
| LSEATVFAQANELEK | 1236 | Q5VU43 |